<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81808</article-id><article-id pub-id-type="doi">10.7554/eLife.81808</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-284781"><name><surname>Olesen</surname><given-names>Tina Bech</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6295-7399</contrib-id><email>forthemanuscripts@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-286059"><name><surname>Jensen</surname><given-names>Henry</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4040-7334</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286060"><name><surname>Møller</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286061"><name><surname>Jensen</surname><given-names>Jens Winther</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286063"><name><surname>Andersen</surname><given-names>Berit</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-286562"><name><surname>Rasmussen</surname><given-names>Morten</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>The Danish Clinical Quality Program – National Clinical Registries (RKKP)</institution><addr-line><named-content content-type="city">Aarhus</named-content></addr-line><country>Denmark</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n00ke18</institution-id><institution>University Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Aarhus</named-content></addr-line><country>Denmark</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01aj84f44</institution-id><institution>Department of Clinical Medicine, Aarhus University</institution></institution-wrap><addr-line><named-content content-type="city">Aarhus</named-content></addr-line><country>Denmark</country></aff><aff id="aff4"><label>4</label><institution>The Colorectal Cancer Screening Programme, the Capital Region</institution><addr-line><named-content content-type="city">Copenhagen</named-content></addr-line><country>Denmark</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00td68a17</institution-id><institution>Abdominal Center, Bispebjerg Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Copenhagen</named-content></addr-line><country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Franco</surname><given-names>Eduardo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Franco</surname><given-names>Eduardo</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>25</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e81808</elocation-id><history><date date-type="received" iso-8601-date="2022-07-12"><day>12</day><month>07</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-01-22"><day>22</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-08-23"><day>23</day><month>08</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.08.18.22278786"/></event></pub-history><permissions><copyright-statement>© 2023, Olesen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Olesen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81808-v2.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.81522" id="ra1"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.83541" id="ra2"/><abstract><sec id="abs1"><title>Background:</title><p>Worldwide, most colorectal cancer screening programmes were paused at the start of the COVID-19 pandemic, while the Danish faecal immunochemical test (FIT)-based programme continued without pausing. We examined colorectal cancer screening participation and compliance with subsequent colonoscopy in Denmark throughout the pandemic.</p></sec><sec id="abs2"><title>Methods:</title><p>We used data from the Danish Colorectal Cancer Screening Database among individuals aged 50–74 years old invited to participate in colorectal cancer screening from 2018 to 2021 combined with population-wide registries. Using a generalised linear model, we estimated prevalence ratios (PRs) and 95% confidence intervals (CIs) of colorectal cancer screening participation within 90 days since invitation and compliance with colonoscopy within 60 days since a positive FIT test during the pandemic in comparison with the previous years adjusting for age, month and year of invitation.</p></sec><sec id="abs3"><title>Results:</title><p>Altogether, 3,133,947 invitations were sent out to 1,928,725 individuals and there were 94,373 positive FIT tests (in 92,848 individuals) during the study period. Before the pandemic, 60.7% participated in screening within 90 days. A minor reduction in participation was observed at the start of the pandemic (PR = 0.95; 95% CI: 0.94–0.96 in pre-lockdown and PR = 0.85; 95% CI: 0.85–0.86 in first lockdown) corresponding to a participation rate of 54.9% during pre-lockdown and 53.0% during first lockdown. This was followed by a 5–10% increased participation in screening corresponding to a participation rate of up to 64.9%. The largest increase in participation was observed among 55–59 years old and among immigrants. The compliance with colonoscopy within 60 days was 89.9% before the pandemic. A slight reduction was observed during first lockdown (PR = 0.96; 95% CI: 0.93–0.98), where after it resumed to normal levels.</p></sec><sec id="abs4"><title>Conclusions:</title><p>Participation in the Danish FIT-based colorectal cancer screening programme and subsequent compliance to colonoscopy after a positive FIT result was only slightly affected by the COVID-19 pandemic.</p></sec><sec id="abs5"><title>Funding:</title><p>The study was funded by the Danish Cancer Society Scientific Committee (Grant number R321-A17417) and the Danish regions.</p></sec></abstract><kwd-group kwd-group-type="author-keywords"><kwd>colorectal cancer screening</kwd><kwd>COVID-19 pandemic</kwd><kwd>epidemiology</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008363</institution-id><institution>The Danish Cancer Society</institution></institution-wrap></funding-source><award-id>R321-A17417</award-id><principal-award-recipient><name><surname>Olesen</surname><given-names>Tina Bech</given-names></name><name><surname>Møller</surname><given-names>Henrik</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>The Danish regions</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Olesen</surname><given-names>Tina Bech</given-names></name><name><surname>Jensen</surname><given-names>Henry</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The participation in the FIT-based colorectal cancer screening programme and subsequent compliance to colonoscopy after a positive FIT test was only slightly affected during the COVID-19 pandemic in Denmark.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The COVID-19 pandemic has impacted the society and the healthcare systems worldwide considerably. In efforts to mitigate the impact of the COVID-19 pandemic on the healthcare system and to minimise the spread of the infection, population-wide restrictions (lockdown) were imposed worldwide. Large parts of the society were closed down and, within the healthcare system, elective procedures were cancelled or postponed and resources were reallocated to take care of patients in need of hospitalisation because of COVID-19.</p><p>As a result of the re-organisations within the healthcare systems, the cancer screening programmes were, in most countries, paused at the start of the pandemic (<xref ref-type="bibr" rid="bib11">Morris et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Dinmohamed et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Kortlever et al., 2021</xref>; <xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Walker et al., 2021</xref>). In Denmark, however, the cancer screening programmes including the faecal immunochemical test (FIT)-based colorectal cancer screening programme using faecal samples obtained at home continued throughout the pandemic. Results from other European countries using FIT-based screening programmes have shown that alterations to the colorectal cancer screening programme at the start of the pandemic led to large reductions in the number of people referred, diagnosed and treated for colorectal cancer at the start of the pandemic (<xref ref-type="bibr" rid="bib11">Morris et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Dinmohamed et al., 2020</xref>) and to reduced participation in screening and screening-derived colonoscopy (<xref ref-type="bibr" rid="bib8">Kortlever et al., 2021</xref>) and longer time interval from a positive screening test to colonoscopy (<xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref>). A study from Canada also found marked reductions in the colorectal cancer faecal test volumes at the start of the pandemic (<xref ref-type="bibr" rid="bib28">Walker et al., 2021</xref>) resulting from a suspension of the FIT-based screening programme. Moreover, it is estimated that the disruptions to the FIT-based colorectal cancer screening programme would result in additional colorectal cancer diagnoses (<xref ref-type="bibr" rid="bib2">de Jonge et al., 2021</xref>). The participation in colorectal cancer screening in Denmark throughout the pandemic has not yet been described–however, one study has shown a 24% reduction in the number of colon cancers diagnosed at the start of the pandemic in Denmark (<xref ref-type="bibr" rid="bib18">Skovlund et al., 2022</xref>) indicating that either the general health-seeking behaviour or the participation in colorectal cancer screening may have changed at the start of the pandemic.</p><p>It is well known that social inequities exist across the entire colorectal cancer screening pathway. For example, studies have shown that younger individuals, immigrants, individuals living alone and individuals with a lower income are less likely to participate in colorectal cancer screening (<xref ref-type="bibr" rid="bib9">Larsen et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Pallesen et al., 2021</xref>). Furthermore, the compliance with colonoscopy is lower among older patients and among patients with underlying disease (<xref ref-type="bibr" rid="bib25">Thomsen et al., 2018</xref>), among immigrants and among individuals living alone (<xref ref-type="bibr" rid="bib14">Pallesen et al., 2021</xref>). A concern is that these social inequities in colorectal cancer screening participation may have been exacerbated during the pandemic.</p><p>We examined the colorectal cancer screening participation and compliance with subsequent colonoscopy during the COVID-19 pandemic in Denmark compared with the previous years. Furthermore, we examined whether the participation in colorectal cancer screening and compliance with screen-derived colonoscopy during the COVID-19 pandemic differed across population sub-groups.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Setting</title><p>The study was conducted in Denmark, which has a population of approximately 5.8 million inhabitants (<xref ref-type="bibr" rid="bib21">Statistics Denmark, 2021</xref>). All residents in Denmark are eligible for tax-supported health care provided by the Danish government. Nationwide population-based registries in Denmark record extensive administrative and medical data of the whole population, which can be linked using the unique personal identifier, that is assigned to all residents at birth or immigration (<xref ref-type="bibr" rid="bib16">Schmidt et al., 2014</xref>–<xref ref-type="bibr" rid="bib17">Schmidt et al., 2019</xref>).</p></sec><sec id="s2-2"><title>The colorectal cancer screening programme</title><p>In Denmark, screening for colorectal cancer was implemented in 2014 and is offered free-of-charge every 2 years to all individuals aged 50–74 years old living in Denmark. The test is a home-based test, which is mailed directly together with an invitation letter to all invitees. The screening procedure is based on a single-sample FIT (OC Sensor; Eiken Chemical Company, Tokyo, Japan), which can detect invisible amounts of blood in stool samples, which may be associated with bleeding lesions from precancerous adenomas or colorectal cancer at early stages of the disease (<xref ref-type="bibr" rid="bib5">Hewitson et al., 2008</xref>; <xref ref-type="bibr" rid="bib4">Garborg et al., 2013</xref>). Non-participants to screening receive a reminder after 6 weeks.</p><p>All individuals with a positive FIT test (≥100 µg haemoglobin/L faeces) receive an invitation for a colonoscopy with a pre-booked time for appointment within 14 days after the positive screening result. Non-participants to colonoscopy are contacted by the administrative regions.</p></sec><sec id="s2-3"><title>The COVID-19 pandemic in Denmark</title><p>In Denmark, three main waves of the COVID-19 pandemic have occurred; in the spring of 2020, in the winter of 2020/2021 and again in the winter of 2021/2022 (<xref ref-type="bibr" rid="bib19">Statens Serum Institut, 2021a</xref>).</p><p>The pandemic response included population-wide restrictions (lockdowns), COVID-19 testing and COVID-19 vaccination. During the lockdowns large parts of the society were closed down and people were advised to stay at home if possible. Large-scale COVID-19 testing was provided free-of-charge to all inhabitants since May 2020 (<xref ref-type="bibr" rid="bib15">Pottegård et al., 2020</xref>). COVID-19 vaccination began in December 2020 and by March 2022, approximately 81% of the population had received two doses and more than 61% had received three doses of the vaccine (<xref ref-type="bibr" rid="bib20">Statens Serum Institut, 2021b</xref>). The vaccination strategy comprised vaccinating individuals living in nursing homes first, thereafter individuals ≥85 years, then healthcare personnel, thereafter individuals with underlying health conditions and their relatives and finally, individuals were offered the COVID-19 vaccination by decreasing age (75–79, 65–74, 60–64 years, etc.) (<xref ref-type="bibr" rid="bib22">Sundhedsstyrelsen, 2021</xref>).</p></sec><sec id="s2-4"><title>Study population</title><p>The study population comprised all invitations in individuals aged 50–74 years old invited to participate in colorectal cancer screening from 1 January 2018 to 30 September 2021, as registered in the Danish Colorectal Cancer Screening Database (<xref ref-type="bibr" rid="bib24">Thomsen et al., 2017</xref>), which contain information on all individuals in Denmark invited to participate in colorectal cancer screening.</p><p>To examine participation in colorectal cancer screening, we excluded invitations in individuals who emigrated within 1 year since invitation (N=11,832), invitations in individuals residing in the Faroe Islands or Greenland (N=540), invitations in individuals with an unknown postal address (N=2621) and registrations of stool samples received before an invitation or reminder was sent out (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Flow-chart of the study population (participation in colorectal cancer screening).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81808-fig1-v2.tif"/></fig><p>To examine compliance with colonoscopy, we included all positive FIT tests from colorectal cancer screening among individuals aged 50–74 years old from 1 January 2018 to 30 September 2021. In all, 146 positive FIT tests were excluded due to low counts across time periods (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Flow-chart of the study population (compliance with colonoscopy).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81808-fig2-v2.tif"/></fig></sec><sec id="s2-5"><title>Exposure of interest</title><p>The COVID-19 pandemic is the exposure of interest. We defined the different phases of the pandemic in Denmark in accordance with the governmental responses to the COVID-19 pandemic in Denmark, as follows:</p><list list-type="bullet"><list-item><p>Pre-pandemic period: 1 January 2018 to 31 January 2020</p></list-item><list-item><p>Pre-lockdown period: 1 February to 10 March 2020</p></list-item><list-item><p>1st lockdown: 11 March to 15 April 2020</p></list-item><list-item><p>1st re-opening: 16 April to 15 December 2020</p></list-item><list-item><p>2nd lockdown: 16 December 2020 to 27 February 2021</p></list-item><list-item><p>2nd re-opening: 28 February 2021 to 30 September 2021 (end of inclusion period)</p></list-item></list><p>Pre-lockdown and first lockdown was termed ‘the start of the pandemic’ in this study.</p><p>The above-mentioned time periods refer to the time of invitation for colorectal cancer screening and the time of a positive FIT result for each of the outcomes of interest.</p></sec><sec id="s2-6"><title>Outcome of interests</title><p>The two main outcomes of interests were colorectal cancer screening participation within 90 days since invitation and compliance with colonoscopy within 60 days since a positive FIT result. Further, we evaluated participation within 180 and 365 days since invitation and compliance with colonoscopy within 365 days since a positive FIT result. We thus calculated the proportion of individuals participating in colorectal cancer screening within 90, 180 and 365 days since invitation and the compliance with colonoscopy within 60 and 365 days since a positive FIT result.</p></sec><sec id="s2-7"><title>Explanatory variables</title><p>The following variables were examined independently: age, sex, ethnicity, cohabitation status, educational level, disposable income and healthcare usage. Age was defined at the date of invitation, as registered in the Danish Colorectal Cancer Screening Database (<xref ref-type="bibr" rid="bib24">Thomsen et al., 2017</xref>). From <xref ref-type="bibr" rid="bib21">Statistics Denmark, 2021</xref>, we obtained information on ethnicity, cohabitation status, educational level and level of income. Ethnicity was categorised as Danish descent, Western immigrant, Non-western immigrant and descendants of immigrants. Cohabitation status was categorised as living alone, cohabiting/co-living, and married (i.e., married or registered partnership) in accordance with <xref ref-type="bibr" rid="bib21">Statistics Denmark, 2021</xref>. Educational level was defined in accordance with the International Standard Classification of Education (ISCED) of the United Nations Education, Scientific and Cultural Organization (UNESCO). We thus categorised level of education into short (ISCED levels 1–2: primary education to upper secondary education), medium (ISCED levels 3–5: vocational education and training to vocational bachelors educations) and long (ISCED levels 6–8: bachelors programmes to PhD programmes) (<xref ref-type="bibr" rid="bib21">Statistics Denmark, 2021</xref>). Income was defined as official disposable income depreciated to 2015 level and categorised into five quintiles. To indicate the level of healthcare use by each patient, we counted the total number of contacts (comprising face-to-face, telephone and e-mail consultations) to general practitioners, private practising medical specialists, physiotherapists and chiropractors in the year for invitation as registered in the Danish National Health Service Register (<xref ref-type="bibr" rid="bib1">Andersen et al., 2011</xref>), which contain information on visits to primary healthcare (e.g., general practitioners and medical specialists) in Denmark since 1990. We categorised healthcare usage into five quintiles of the data as rare (0–3 visits per year), low (4–6 visits per year), average (7–11 visits per year), high (12–18 visits per year) and frequent (≥19 visits per year).</p><p>Information on cohabitation status was only available from Statistics Denmark until the end of February 2021, whereas all other socioeconomic variables were available until end of the study period.</p></sec><sec id="s2-8"><title>Statistical analyses</title><p>We examined characteristics of persons invited to participate in colorectal cancer screening and characteristics of persons with a positive FIT test during the study period. Thereafter, we examined the participation in colorectal cancer screening within 90, 180 and 365 days since invitation overall and stratifying by the explanatory variables per month and during the pandemic phases. Similarly, we examined compliance with colonoscopy within 60 and 365 days since a positive FIT test overall and stratifying by the explanatory variables per month and during the pandemic phases. We also examined the median number of days and interdecentile interval (IDI) from invitation to participation overall and during the different phases of the pandemic, among individuals eventually participating in the screening programme.</p><p>Using a generalised linear model (GLM) with log link for the Poisson family with robust standard errors (SEs), we estimated prevalence ratios (PRs) and 95% confidence intervals (CIs) of participation in colorectal cancer screening within 90, 180 and 365 days since invitation among persons invited to participate in colorectal cancer screening and compliance with colonoscopy within 60 and 365 days since a positive FIT test during the different phases of the pandemic overall and stratifying by the explanatory variables. First, we calculated unadjusted analyses. Thereafter, the analyses were adjusted for month of invitation to allow for seasonality and year of invitation to take into account the annual change in colorectal cancer screening participation. Finally, the analyses were adjusted for age to take into account the effect of age on the other explanatory variables.</p><p>We performed a sensitivity analysis to take into account an IT-error that occurred in the spring of 2020 resulting in a reduction in the number of invitations sent out in weeks 11–14 2020 (Central Denmark Region in weeks 11–14 2020, Northern Denmark Region in weeks 12–14 2020 and the rest of Denmark in weeks 13–14 2020). The error meant, that only individuals entering or leaving the screening programme were invited. Thus, during the period with the IT-error only 50 years olds entering the programme, individuals entering the country from abroad, and 73–74 years old leaving the programme were invited. We re-ran the analyses for this by introducing a dummy variable expressing the IT-error in the GLM model.</p><p>All analyses were conducted using STATA version 17.0.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>Altogether, 3,133,947 invitations were sent out to 1,928,725 individuals during the study period. Among those 50.5% were women and the median age was 60 years (IQI = 54–67), the majority were of Danish descent (91.4%), most were married (59.4%) and 56% had a short educational level. The distribution of the descriptive characteristics was similar across the pandemic phases (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Baseline characteristics of people invited to participate in colorectal cancer screening in Denmark from 2018 to 2021.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2"/><th align="left" valign="bottom">Pre-pandemic (1 January 2018 to 31 January 2020)</th><th align="left" valign="bottom">Pre-lockdown (1 February 2020 to 10 March 2020)</th><th align="left" valign="bottom">1st lockdown (11 March 2020 to 15 April 2020)</th><th align="left" valign="bottom">1st re-opening (16 April 2020 to 15 December 2020)</th><th align="left" valign="bottom">2nd lockdown (16 December 2020 to 27 February 2021)</th><th align="left" valign="bottom">2nd re-opening (28 February 2021 to 30 September 2021)</th><th align="left" valign="bottom">Total</th></tr><tr><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Total</bold></td><td align="char" char="." valign="bottom">1,804,770 (57.6)</td><td align="char" char="." valign="bottom">104,892 (3.3)</td><td align="char" char="." valign="bottom">40,146 (1.3)</td><td align="char" char="." valign="bottom">562,124 (17.9)</td><td align="char" char="." valign="bottom">176,469 (5.6)</td><td align="char" char="." valign="bottom">445,546 (14.2)</td><td align="char" char="." valign="bottom">3,133,947 (100.0)</td></tr><tr><td align="left" valign="bottom"><bold>Sex</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Men</td><td align="char" char="." valign="bottom">893,009 (49.5)</td><td align="char" char="." valign="bottom">52,523 (50.1)</td><td align="char" char="." valign="bottom">19,285 (48.0)</td><td align="char" char="." valign="bottom">276,731 (49.2)</td><td align="char" char="." valign="bottom">87,667 (49.7)</td><td align="char" char="." valign="bottom">218,713 (49.1)</td><td align="char" char="." valign="bottom">1,547,928 (49.4)</td></tr><tr><td align="left" valign="bottom">Women</td><td align="char" char="." valign="bottom">911,761 (50.5)</td><td align="char" char="." valign="bottom">52,369 (49.9)</td><td align="char" char="." valign="bottom">20,861 (52.0)</td><td align="char" char="." valign="bottom">285,393 (50.8)</td><td align="char" char="." valign="bottom">88,802 (50.3)</td><td align="char" char="." valign="bottom">226,833 (50.9)</td><td align="char" char="." valign="bottom">1,586,019 (50.6)</td></tr><tr><td align="left" valign="bottom"><bold>Age at invitation</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">50–54 years</td><td align="char" char="." valign="bottom">478,804 (26.5)</td><td align="char" char="." valign="bottom">14,982 (14.3)</td><td align="char" char="." valign="bottom">7322 (18.2)</td><td align="char" char="." valign="bottom">127,306 (22.6)</td><td align="char" char="." valign="bottom">49,217 (27.9)</td><td align="char" char="." valign="bottom">138,988 (31.2)</td><td align="char" char="." valign="bottom">816,619 (26.1)</td></tr><tr><td align="char" char="." valign="bottom">55–59 years</td><td align="char" char="." valign="bottom">375,309 (20.8)</td><td align="char" char="." valign="bottom">38,988 (37.2)</td><td align="char" char="." valign="bottom">5739 (14.3)</td><td align="char" char="." valign="bottom">150,615 (26.8)</td><td align="char" char="." valign="bottom">32,217 (18.3)</td><td align="char" char="." valign="bottom">61,318 (13.8)</td><td align="char" char="." valign="bottom">664,186 (21.2)</td></tr><tr><td align="char" char="." valign="bottom">60–64 years</td><td align="char" char="." valign="bottom">332,766 (18.4)</td><td align="char" char="." valign="bottom">18,089 (17.2)</td><td align="char" char="." valign="bottom">2929 (7.3)</td><td align="char" char="." valign="bottom">101,925 (18.1)</td><td align="char" char="." valign="bottom">33,503 (19.0)</td><td align="char" char="." valign="bottom">86,806 (19.5)</td><td align="char" char="." valign="bottom">576,018 (18.4)</td></tr><tr><td align="char" char="." valign="bottom">65–69 years</td><td align="char" char="." valign="bottom">308,725 (17.1)</td><td align="char" char="." valign="bottom">16,334 (15.6)</td><td align="char" char="." valign="bottom">2859 (7.1)</td><td align="char" char="." valign="bottom">92,026 (16.4)</td><td align="char" char="." valign="bottom">30,398 (17.2)</td><td align="char" char="." valign="bottom">79,821 (17.9)</td><td align="char" char="." valign="bottom">530,163 (16.9)</td></tr><tr><td align="char" char="." valign="bottom">70–74 years</td><td align="char" char="." valign="bottom">309,166 (17.1)</td><td align="char" char="." valign="bottom">16,499 (15.7)</td><td align="char" char="." valign="bottom">21,297 (53.0)</td><td align="char" char="." valign="bottom">90,252 (16.1)</td><td align="char" char="." valign="bottom">31,134 (17.6)</td><td align="char" char="." valign="bottom">78,613 (17.6)</td><td align="char" char="." valign="bottom">546,961 (17.5)</td></tr><tr><td align="left" valign="bottom">Median (IQI)</td><td align="char" char="." valign="bottom">60 (54–67)</td><td align="char" char="." valign="bottom">59 (55–66)</td><td align="char" char="." valign="bottom">72 (56–75)</td><td align="char" char="." valign="bottom">60 (55–67)</td><td align="char" char="." valign="bottom">60 (54–67)</td><td align="char" char="." valign="bottom">61 (54–67)</td><td align="char" char="." valign="bottom">60 (54–67)</td></tr><tr><td align="left" valign="bottom"><bold>Ethnicity</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Danish descent</td><td align="char" char="." valign="bottom">1,651,658 (91.6)</td><td align="char" char="." valign="bottom">95,490 (91.1)</td><td align="char" char="." valign="bottom">36,665 (91.4)</td><td align="char" char="." valign="bottom">512,355 (91.2)</td><td align="char" char="." valign="bottom">150,194 (91.0)</td><td align="char" char="." valign="bottom">366,141 (91.2)</td><td align="char" char="." valign="bottom">2,812,503 (91.4)</td></tr><tr><td align="left" valign="bottom">Descendant of immigrant</td><td align="char" char="." valign="bottom">2932 (0.2)</td><td align="char" char="." valign="bottom">169 (0.2)</td><td align="char" char="." valign="bottom">65 (0.2)</td><td align="char" char="." valign="bottom">987 (0.2)</td><td align="char" char="." valign="bottom">284 (0.2)</td><td align="char" char="." valign="bottom">617 (0.2)</td><td align="char" char="." valign="bottom">5054 (0.2)</td></tr><tr><td align="left" valign="bottom">Western immigrant</td><td align="char" char="." valign="bottom">48,061 (2.7)</td><td align="char" char="." valign="bottom">2871 (2.7)</td><td align="char" char="." valign="bottom">1164 (2.9)</td><td align="char" char="." valign="bottom">15,877 (2.8)</td><td align="char" char="." valign="bottom">4642 (2.8)</td><td align="char" char="." valign="bottom">10,902 (2.7)</td><td align="char" char="." valign="bottom">83,517 (2.7)</td></tr><tr><td align="left" valign="bottom">Non-western immigrant</td><td align="char" char="." valign="bottom">99,730 (5.5)</td><td align="char" char="." valign="bottom">6334 (6.0)</td><td align="char" char="." valign="bottom">2238 (5.6)</td><td align="char" char="." valign="bottom">32,755 (5.8)</td><td align="char" char="." valign="bottom">9939 (6.0)</td><td align="char" char="." valign="bottom">23,620 (5.9)</td><td align="char" char="." valign="bottom">174,616 (5.7)</td></tr><tr><td align="left" valign="bottom"><bold>Cohabitation status</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Living alone</td><td align="char" char="." valign="bottom">567,436 (31.5)</td><td align="char" char="." valign="bottom">34,149 (32.6)</td><td align="char" char="." valign="bottom">14,487 (36.1)</td><td align="char" char="." valign="bottom">177,512 (31.6)</td><td align="char" char="." valign="bottom">51,320 (31.1)</td><td align="char" char="." valign="bottom">120,737 (30.1)</td><td align="char" char="." valign="bottom">965,641 (31.4)</td></tr><tr><td align="left" valign="bottom">Cohabiting/co-living</td><td align="char" char="." valign="bottom">163,186 (9.1)</td><td align="char" char="." valign="bottom">9679 (9.2)</td><td align="char" char="." valign="bottom">2758 (6.9)</td><td align="char" char="." valign="bottom">53,372 (9.5)</td><td align="char" char="." valign="bottom">15,775 (9.6)</td><td align="char" char="." valign="bottom">37,404 (9.3)</td><td align="char" char="." valign="bottom">282,174 (9.2)</td></tr><tr><td align="left" valign="bottom">Married/registered partner</td><td align="char" char="." valign="bottom">1,071,632 (59.5)</td><td align="char" char="." valign="bottom">61,036 (58.2)</td><td align="char" char="." valign="bottom">22,887 (57.0)</td><td align="char" char="." valign="bottom">331,090 (58.9)</td><td align="char" char="." valign="bottom">97,964 (59.4)</td><td align="char" char="." valign="bottom">243,139 (60.6)</td><td align="char" char="." valign="bottom">1,827,748 (59.4)</td></tr><tr><td align="left" valign="bottom"><bold>Educational level (ISCED</bold>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">ISCED15 levels 1–2</td><td align="char" char="." valign="bottom">976,876 (55.1)</td><td align="char" char="." valign="bottom">58,698 (57.0)</td><td align="char" char="." valign="bottom">18,575 (47.2)</td><td align="char" char="." valign="bottom">316,639 (57.3)</td><td align="char" char="." valign="bottom">98,365 (56.8)</td><td align="char" char="." valign="bottom">250,198 (57.2)</td><td align="char" char="." valign="bottom">1,719,351 (55.9)</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 3–5</td><td align="char" char="." valign="bottom">597,535 (33.7)</td><td align="char" char="." valign="bottom">33,332 (32.3)</td><td align="char" char="." valign="bottom">15,297 (38.8)</td><td align="char" char="." valign="bottom">177,249 (32.1)</td><td align="char" char="." valign="bottom">55,821 (32.2)</td><td align="char" char="." valign="bottom">139,785 (32.0)</td><td align="char" char="." valign="bottom">1,019,019 (33.1)</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 6–8</td><td align="char" char="." valign="bottom">198,531 (11.2)</td><td align="char" char="." valign="bottom">11,011 (10.7)</td><td align="char" char="." valign="bottom">5513 (14.0)</td><td align="char" char="." valign="bottom">58,592 (10.6)</td><td align="char" char="." valign="bottom">18,970 (11.0)</td><td align="char" char="." valign="bottom">47,211 (10.8)</td><td align="char" char="." valign="bottom">339,828 (11.0)</td></tr><tr><td align="left" valign="bottom"><bold>Disposable income</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Lowest quintile</td><td align="char" char="." valign="bottom">353,612 (19.6)</td><td align="char" char="." valign="bottom">18,722 (17.9)</td><td align="char" char="." valign="bottom">9939 (24.8)</td><td align="char" char="." valign="bottom">97,358 (17.4)</td><td align="char" char="." valign="bottom">29,966 (17.0)</td><td align="char" char="." valign="bottom">74,581 (16.8)</td><td align="char" char="." valign="bottom">584,178 (18.7)</td></tr><tr><td align="left" valign="bottom">Second quintile</td><td align="char" char="." valign="bottom">358,955 (19.9)</td><td align="char" char="." valign="bottom">20,579 (19.7)</td><td align="char" char="." valign="bottom">9583 (23.9)</td><td align="char" char="." valign="bottom">105,809 (18.9)</td><td align="char" char="." valign="bottom">33,736 (19.2)</td><td align="char" char="." valign="bottom">83,982 (18.9)</td><td align="char" char="." valign="bottom">612,644 (19.6)</td></tr><tr><td align="left" valign="bottom">Third quintile</td><td align="char" char="." valign="bottom">366,888 (20.3)</td><td align="char" char="." valign="bottom">21,023 (20.1)</td><td align="char" char="." valign="bottom">7332 (18.3)</td><td align="char" char="." valign="bottom">114,154 (20.4)</td><td align="char" char="." valign="bottom">33,347 (18.9)</td><td align="char" char="." valign="bottom">82,529 (18.6)</td><td align="char" char="." valign="bottom">625,273 (20.0)</td></tr><tr><td align="left" valign="bottom">Fourth quintile</td><td align="char" char="." valign="bottom">366,219 (20.3)</td><td align="char" char="." valign="bottom">21,767 (20.8)</td><td align="char" char="." valign="bottom">6614 (16.5)</td><td align="char" char="." valign="bottom">119,544 (21.3)</td><td align="char" char="." valign="bottom">36,705 (20.8)</td><td align="char" char="." valign="bottom">94,378 (21.2)</td><td align="char" char="." valign="bottom">645,227 (20.6)</td></tr><tr><td align="left" valign="bottom">Highest quintile</td><td align="char" char="." valign="bottom">358,608 (19.9)</td><td align="char" char="." valign="bottom">22,588 (21.6)</td><td align="char" char="." valign="bottom">6644 (16.6)</td><td align="char" char="." valign="bottom">123,676 (22.1)</td><td align="char" char="." valign="bottom">42,412 (24.1)</td><td align="char" char="." valign="bottom">108,662 (24.5)</td><td align="char" char="." valign="bottom">662,590 (21.2)</td></tr><tr><td align="left" valign="bottom"><bold>Healthcare usage</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Rare</td><td align="char" char="." valign="bottom">386,510 (21.4)</td><td align="char" char="." valign="bottom">23,944 (22.8)</td><td align="char" char="." valign="bottom">7293 (18.2)</td><td align="char" char="." valign="bottom">125,799 (22.4)</td><td align="char" char="." valign="bottom">37,849 (21.4)</td><td align="char" char="." valign="bottom">95,024 (21.3)</td><td align="char" char="." valign="bottom">676,419 (21.6)</td></tr><tr><td align="left" valign="bottom">Low</td><td align="char" char="." valign="bottom">338,179 (18.7)</td><td align="char" char="." valign="bottom">18,944 (18.1)</td><td align="char" char="." valign="bottom">6054 (15.1)</td><td align="char" char="." valign="bottom">103,813 (18.5)</td><td align="char" char="." valign="bottom">32,147 (18.2)</td><td align="char" char="." valign="bottom">80,134 (18.0)</td><td align="char" char="." valign="bottom">579,271 (18.5)</td></tr><tr><td align="left" valign="bottom">Average</td><td align="char" char="." valign="bottom">401,358 (22.2)</td><td align="char" char="." valign="bottom">23,271 (22.2)</td><td align="char" char="." valign="bottom">8569 (21.3)</td><td align="char" char="." valign="bottom">125,600 (22.3)</td><td align="char" char="." valign="bottom">39,176 (22.2)</td><td align="char" char="." valign="bottom">98,833 (22.2)</td><td align="char" char="." valign="bottom">696,807 (22.2)</td></tr><tr><td align="left" valign="bottom">High</td><td align="char" char="." valign="bottom">333,529 (18.5)</td><td align="char" char="." valign="bottom">19,230 (18.3)</td><td align="char" char="." valign="bottom">8343 (20.8)</td><td align="char" char="." valign="bottom">104,646 (18.6)</td><td align="char" char="." valign="bottom">33,618 (19.1)</td><td align="char" char="." valign="bottom">85,706 (19.2)</td><td align="char" char="." valign="bottom">585,072 (18.7)</td></tr><tr><td align="left" valign="bottom">Frequent</td><td align="char" char="." valign="bottom">345,194 (19.1)</td><td align="char" char="." valign="bottom">19,503 (18.6)</td><td align="char" char="." valign="bottom">9887 (24.6)</td><td align="char" char="." valign="bottom">102,266 (18.2)</td><td align="char" char="." valign="bottom">33,679 (19.1)</td><td align="char" char="." valign="bottom">85,849 (19.3)</td><td align="char" char="." valign="bottom">596,378 (19.0)</td></tr><tr><td align="left" valign="bottom"><bold>Time from invitation to participation,</bold> median (IDI)</td><td align="char" char="." valign="bottom">28 (16–72)</td><td align="char" char="." valign="bottom">25 (15–78)</td><td align="char" char="." valign="bottom">32 (16–64)</td><td align="char" char="." valign="bottom">28 (16–66)</td><td align="char" char="." valign="bottom">24 (16–63)</td><td align="char" char="." valign="bottom">25 (16–59)</td><td align="char" char="." valign="bottom">28 (16–70)</td></tr></tbody></table><table-wrap-foot><fn><p>IQI = interquartile interval.; IDI = interdecentile interval.; ISCED = International Standard Classification of Education.</p></fn></table-wrap-foot></table-wrap><sec id="s3-1"><title>Participation during the COVID-19 pandemic</title><p>Before the pandemic, 60.7% participated in colorectal cancer screening within 90 days since invitation (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The results were similar extending the length of follow-up time to 180 and 365 days (data not shown).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Participation in colorectal cancer screening (%) in Denmark within 90, 180 and 365 days since invitation from 2018 to 2021.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81808-fig3-v2.tif"/></fig><p>A reduction in screening participation within 90 days occurred during February and March 2020 (<xref ref-type="fig" rid="fig1">Figure 1</xref>) reflected in a PR of 0.95 (95% CI: 0.94–0.96) during pre-lockdown and a PR of 0.85 (95% CI: 0.85–0.86) during first lockdown (<xref ref-type="table" rid="table2">Table 2</xref>). This reduction corresponded to an overall participation rate of 54.9% during pre-lockdown and 53.3% during first lockdown (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Subsequently, an increase in screening participation was observed (<xref ref-type="fig" rid="fig1">Figure 1</xref>) reflected in overall PRs of 1.04 (95% CI: 1.04–1.05), 1.09 (95% CI: 1.09–1.10) and 1.11 (95% CI: 1.10–1.12) during first re-opening, second lockdown and second re-opening, respectively (<xref ref-type="table" rid="table2">Table 2</xref>). These increases corresponded to participation rates of 62.4% during first re-opening, 63.0% during second lockdown and 64.9% during second re-opening (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These estimates were similar when extending the length of follow-up time to 180 and 365 days (data not shown).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Prevalence ratios (PRs) and 95% confidence intervals (CIs) of participation in colorectal cancer screening within 90 days since invitation in Denmark 2018–2021<xref ref-type="table-fn" rid="table2fn1"><sup>*</sup></xref>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="3"/><th align="left" valign="bottom" rowspan="3">N</th><th align="left" valign="bottom" colspan="2">Pre-pandemic (1 January 2018 to 31 January 2020)</th><th align="left" valign="bottom" colspan="2">Pre-lockdown (1 February 2020 to 10 March 2020)</th><th align="left" valign="bottom" colspan="2">1st lockdown (11 March 2020 to 15 April 2020)</th><th align="left" valign="bottom" colspan="2">1st re-opening (16 April 2020 to 15 December 2020)</th><th align="left" valign="bottom" colspan="2">2nd lockdown (16 December 2020 to 27 February 2021)</th><th align="left" valign="bottom" colspan="2">2nd re-opening (28 February 2021 to 30 September 2021)</th></tr><tr><th align="left" valign="bottom" colspan="2">N=180,477</th><th align="left" valign="bottom" colspan="2">N=104,892</th><th align="left" valign="bottom" colspan="2">N=40,146</th><th align="left" valign="bottom" colspan="2">N=562,124</th><th align="left" valign="bottom" colspan="2">N=176,469</th><th align="left" valign="bottom" colspan="2">N=445,546</th></tr><tr><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Overall</bold></td><td align="char" char="." valign="bottom">3,133,947</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.96]</td><td align="char" char="." valign="bottom">0.85</td><td align="char" char="." valign="bottom">[0.85–0.86]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.09–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td></tr><tr><td align="left" valign="bottom"><bold>Sex</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Men</td><td align="char" char="." valign="bottom">1,547,928</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.88</td><td align="char" char="." valign="bottom">[0.88–0.89]</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">[0.89–0.92]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.02–1.03]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.07</td><td align="char" char="." valign="bottom">[1.07–1.08]</td></tr><tr><td align="left" valign="bottom">Women</td><td align="char" char="." valign="bottom">1,586,019</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">[0.92–0.93]</td><td align="char" char="." valign="bottom">0.84</td><td align="char" char="." valign="bottom">[0.83–0.85]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.02–1.03]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.03–1.04]</td><td align="char" char="." valign="bottom">1.06</td><td align="char" char="." valign="bottom">[1.06–1.07]</td></tr><tr><td align="left" valign="bottom"><bold>Age at invitation</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">50–54 years</td><td align="char" char="." valign="bottom">816,619</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.89</td><td align="char" char="." valign="bottom">[0.87–0.91]</td><td align="char" char="." valign="bottom">1.14</td><td align="char" char="." valign="bottom">[1.12–1.17]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.99–1.01]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.06]</td><td align="char" char="." valign="bottom">1.16</td><td align="char" char="." valign="bottom">[1.14–1.18]</td></tr><tr><td align="char" char="." valign="bottom">55–59 years</td><td align="char" char="." valign="bottom">664,186</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.93</td><td align="char" char="." valign="bottom">[0.91–0.94]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.06–1.11]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td><td align="char" char="." valign="bottom">1.24</td><td align="char" char="." valign="bottom">[1.22–1.25]</td><td align="char" char="." valign="bottom">1.18</td><td align="char" char="." valign="bottom">[1.16–1.19]</td></tr><tr><td align="char" char="." valign="bottom">60–64 years</td><td align="char" char="." valign="bottom">576,018</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.93–0.96]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.00–1.06]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.02–1.04]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.07–1.10]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.07–1.10]</td></tr><tr><td align="char" char="." valign="bottom">65–69 years</td><td align="char" char="." valign="bottom">530,163</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.95–0.97]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.02]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[1.01–1.03]</td><td align="char" char="." valign="bottom">1.07</td><td align="char" char="." valign="bottom">[1.06–1.09]</td><td align="char" char="." valign="bottom">1.07</td><td align="char" char="." valign="bottom">[1.06–1.08]</td></tr><tr><td align="char" char="." valign="bottom">70–74 years</td><td align="char" char="." valign="bottom">546,961</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[1.00–1.03]</td><td align="char" char="." valign="bottom">0.77</td><td align="char" char="." valign="bottom">[0.76–0.79]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.07–1.10]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.08–1.11]</td></tr><tr><td align="left" valign="bottom"><bold>Ethnicity</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Danish descent</td><td align="char" char="." valign="bottom">2,812,503</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.95]</td><td align="char" char="." valign="bottom">0.85</td><td align="char" char="." valign="bottom">[0.84–0.86]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td></tr><tr><td align="left" valign="bottom">Descendant of immigrant</td><td align="char" char="." valign="bottom">5054</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.79–1.14]</td><td align="char" char="." valign="bottom">0.83</td><td align="char" char="." valign="bottom">[0.62–1.11]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[0.93–1.17]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[0.91–1.28]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[0.94–1.32]</td></tr><tr><td align="left" valign="bottom">Western Immigrant</td><td align="char" char="." valign="bottom">83,517</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.91–1.00]</td><td align="char" char="." valign="bottom">0.88</td><td align="char" char="." valign="bottom">[0.82–0.94]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.05–1.11]</td><td align="char" char="." valign="bottom">1.16</td><td align="char" char="." valign="bottom">[1.11–1.21]</td><td align="char" char="." valign="bottom">1.20</td><td align="char" char="." valign="bottom">[1.15–1.25]</td></tr><tr><td align="left" valign="bottom">Non-western immigrant</td><td align="char" char="." valign="bottom">174,616</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.94–1.00]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.95–1.05]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.09–1.13]</td><td align="char" char="." valign="bottom">1.18</td><td align="char" char="." valign="bottom">[1.15–1.22]</td><td align="char" char="." valign="bottom">1.24</td><td align="char" char="." valign="bottom">[1.20–1.28]</td></tr><tr><td align="left" valign="bottom"><bold>Cohabitation status</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Living alone</td><td align="char" char="." valign="bottom">965,641</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.93–0.95]</td><td align="char" char="." valign="bottom">0.85</td><td align="char" char="." valign="bottom">[0.83–0.87]</td><td align="char" char="." valign="bottom">1.06</td><td align="char" char="." valign="bottom">[1.05–1.07]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[1.11–1.14]</td><td align="char" char="." valign="bottom">1.16</td><td align="char" char="." valign="bottom">[1.14–1.17]</td></tr><tr><td align="left" valign="bottom">Cohabiting/co-living</td><td align="char" char="." valign="bottom">282,174</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.92–0.97]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.93–1.00]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.07]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[1.09–1.14]</td><td align="char" char="." valign="bottom">1.14</td><td align="char" char="." valign="bottom">[1.12–1.17]</td></tr><tr><td align="left" valign="bottom">Married/registered partner</td><td align="char" char="." valign="bottom">1,827,748</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.95–0.96]</td><td align="char" char="." valign="bottom">0.86</td><td align="char" char="." valign="bottom">[0.85–0.87]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.04]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.07–1.09]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.09–1.10]</td></tr><tr><td align="left" valign="bottom"><bold>Educational level (ISCED</bold>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">ISCED15 levels 1–2</td><td align="char" char="." valign="bottom">1,719,351</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.95]</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">[0.90–0.92]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.10]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[1.11–1.13]</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 3–5</td><td align="char" char="." valign="bottom">1,019,019</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.80</td><td align="char" char="." valign="bottom">[0.79–0.82]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.04]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.10]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.09–1.11]</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 6–8</td><td align="char" char="." valign="bottom">339,828</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.83</td><td align="char" char="." valign="bottom">[0.81–0.85]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.06]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.09–1.13]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[1.10–1.13]</td></tr><tr><td align="left" valign="bottom"><bold>Disposable income</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Lowest quintile</td><td align="char" char="." valign="bottom">584,178</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.73</td><td align="char" char="." valign="bottom">[0.71–0.75]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.05]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.06–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.09–1.12]</td></tr><tr><td align="left" valign="bottom">Second quintile</td><td align="char" char="." valign="bottom">612,644</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.95–0.98]</td><td align="char" char="." valign="bottom">0.78</td><td align="char" char="." valign="bottom">[0.76–0.79]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.06]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.08–1.11]</td><td align="char" char="." valign="bottom">1.13</td><td align="char" char="." valign="bottom">[1.11–1.14]</td></tr><tr><td align="left" valign="bottom">Third quintile</td><td align="char" char="." valign="bottom">625,273</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.86</td><td align="char" char="." valign="bottom">[0.84–0.88]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.06]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.07–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td></tr><tr><td align="left" valign="bottom">Fourth quintile</td><td align="char" char="." valign="bottom">645,227</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.96]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.92–0.96]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">[1.07–1.10]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.09–1.11]</td></tr><tr><td align="left" valign="bottom">Highest quintile</td><td align="char" char="." valign="bottom">662,590</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.93</td><td align="char" char="." valign="bottom">[0.92–0.94]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.05]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.09–1.11]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.09–1.11]</td></tr><tr><td align="left" valign="bottom"><bold>Healthcare usage</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Rare</td><td align="char" char="." valign="bottom">676,419</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">[0.90–0.93]</td><td align="char" char="." valign="bottom">0.93</td><td align="char" char="." valign="bottom">[0.90–0.95]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.05]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.08–1.12]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.09–1.12]</td></tr><tr><td align="left" valign="bottom">Low</td><td align="char" char="." valign="bottom">579,271</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.90</td><td align="char" char="." valign="bottom">[0.88–0.92]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.06]</td><td align="char" char="." valign="bottom">1.10</td><td align="char" char="." valign="bottom">[1.08–1.11]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.13]</td></tr><tr><td align="left" valign="bottom">Average</td><td align="char" char="." valign="bottom">696,807</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.94–0.97]</td><td align="char" char="." valign="bottom">0.86</td><td align="char" char="." valign="bottom">[0.85–0.88]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.06]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td></tr><tr><td align="left" valign="bottom">High</td><td align="char" char="." valign="bottom">585,072</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.95–0.98]</td><td align="char" char="." valign="bottom">0.84</td><td align="char" char="." valign="bottom">[0.82–0.86]</td><td align="char" char="." valign="bottom">1.05</td><td align="char" char="." valign="bottom">[1.04–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.11]</td><td align="char" char="." valign="bottom">1.12</td><td align="char" char="." valign="bottom">[1.10–1.13]</td></tr><tr><td align="left" valign="bottom">Frequent</td><td align="char" char="." valign="bottom">596,378</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.95–0.98]</td><td align="char" char="." valign="bottom">0.81</td><td align="char" char="." valign="bottom">[0.79–0.83]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.03–1.05]</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">[1.08–1.10]</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">[1.10–1.12]</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><label>*</label><p>Adjusted for year, month and age at invitation; PR = prevalence ratio; CI = confidence interval; ISCED = International Standard Classification of Education.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2"><title>Participation during the COVID-19 pandemic according to socio-economic variables</title><p>Throughout the study period, the participation in colorectal cancer screening was lowest among the youngest age group, among men, among immigrants, among individuals living alone or cohabiting, among individuals with a low educational level, a low income and among individuals who rarely use the healthcare system (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). During first lockdown, women, 70–74 years old and individuals with a low income had the lowest participation in screening. From first re-opening and onwards, the largest relative increases in participation was observed among 55–59 years old and among immigrants (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3-3"><title>Participation among first-time invitees</title><p>Altogether, 8.8% (N=276,495) of the study population were first-time invitees. The median age of first-time invitees was 50 years old (IQI: 50–50), 15% were immigrants and 33% rarely used the primary healthcare system (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Before the pandemic, 53% of first-time invitees participated in screening within 90 days, 54% within 180 days and 55% within 365 days (data not shown). A slight reduction in participation within 90 days was observed during pre-lockdown (PR = 0.95; 95% CI: 0.93–0.98), an increase in participation was found during first lockdown (PR = 1.06; 95% CI: 1.03–1.09), whereas the participation was similar to the previous years for the remaining part of the study period (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Baseline characteristics of people with a positive FIT test from colorectal cancer screening in Denmark from 2018 to 2021.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2"/><th align="left" valign="bottom">Pre-pandemic (1 January 2018 to 31 January 2020)</th><th align="left" valign="bottom">Pre-lockdown (1 February 2020 to 10 March 2020)</th><th align="left" valign="bottom">1st lockdown (11 March 2020 to 15 April 2020)</th><th align="left" valign="bottom">1st re-opening (16 April 2020 to 15 December 2020)</th><th align="left" valign="bottom">2nd lockdown (16 December 2020 to 27 Febraury 2021)</th><th align="left" valign="bottom">2nd re-opening (28 February 2021 to 30 September 2021)</th><th align="left" valign="bottom">Total</th></tr><tr><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th><th align="left" valign="bottom">N (%)</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Total</bold></td><td align="char" char="." valign="bottom">54,886 (58.2)</td><td align="char" char="." valign="bottom">2942 (3.1)</td><td align="char" char="." valign="bottom">1319 (1.4)</td><td align="char" char="." valign="bottom">16,628 (17.6)</td><td align="char" char="." valign="bottom">5383 (5.7)</td><td align="char" char="." valign="bottom">13,215 (14.0)</td><td align="char" char="." valign="bottom">94,373 (100.0)</td></tr><tr><td align="left" valign="bottom"><bold>Sex</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Men</td><td align="char" char="." valign="bottom">29,880 (54.4)</td><td align="char" char="." valign="bottom">1532 (52.1)</td><td align="char" char="." valign="bottom">704 (53.4)</td><td align="char" char="." valign="bottom">8796 (52.9)</td><td align="char" char="." valign="bottom">2835 (52.7)</td><td align="char" char="." valign="bottom">6918 (52.3)</td><td align="char" char="." valign="bottom">50,665 (53.7)</td></tr><tr><td align="left" valign="bottom">Women</td><td align="char" char="." valign="bottom">25,006 (45.6)</td><td align="char" char="." valign="bottom">1410 (47.9)</td><td align="char" char="." valign="bottom">615 (46.6)</td><td align="char" char="." valign="bottom">7832 (47.1)</td><td align="char" char="." valign="bottom">2548 (47.3)</td><td align="char" char="." valign="bottom">6297 (47.7)</td><td align="char" char="." valign="bottom">43,708 (46.3)</td></tr><tr><td align="left" valign="bottom"><bold>Age at invitation</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">50–54 years</td><td align="char" char="." valign="bottom">9481 (17.3)</td><td align="char" char="." valign="bottom">291 (9.9)</td><td align="char" char="." valign="bottom">185 (14.0)</td><td align="char" char="." valign="bottom">2615 (15.7)</td><td align="char" char="." valign="bottom">987 (18.3)</td><td align="char" char="." valign="bottom">2876 (21.8)</td><td align="char" char="." valign="bottom">16,435 (17.4)</td></tr><tr><td align="char" char="." valign="bottom">55–59 years</td><td align="char" char="." valign="bottom">8606 (15.7)</td><td align="char" char="." valign="bottom">838 (28.5)</td><td align="char" char="." valign="bottom">157 (11.9)</td><td align="char" char="." valign="bottom">3536 (21.3)</td><td align="char" char="." valign="bottom">813 (15.1)</td><td align="char" char="." valign="bottom">1479 (11.2)</td><td align="char" char="." valign="bottom">15,429 (16.3)</td></tr><tr><td align="char" char="." valign="bottom">60–64 years</td><td align="char" char="." valign="bottom">10,343 (18.8)</td><td align="char" char="." valign="bottom">524 (17.8)</td><td align="char" char="." valign="bottom">78 (5.9)</td><td align="char" char="." valign="bottom">2944 (17.7)</td><td align="char" char="." valign="bottom">1000 (18.6)</td><td align="char" char="." valign="bottom">2433 (18.4)</td><td align="char" char="." valign="bottom">17,322 (18.4)</td></tr><tr><td align="char" char="." valign="bottom">65–69 years</td><td align="char" char="." valign="bottom">12,126 (22.1)</td><td align="char" char="." valign="bottom">559 (19.0)</td><td align="char" char="." valign="bottom">111 (8.4)</td><td align="char" char="." valign="bottom">3526 (21.2)</td><td align="char" char="." valign="bottom">1165 (21.6)</td><td align="char" char="." valign="bottom">2888 (21.9)</td><td align="char" char="." valign="bottom">20,375 (21.6)</td></tr><tr><td align="char" char="." valign="bottom">70–74 years</td><td align="char" char="." valign="bottom">14,330 (26.1)</td><td align="char" char="." valign="bottom">730 (24.8)</td><td align="char" char="." valign="bottom">788 (59.7)</td><td align="char" char="." valign="bottom">4007 (24.1)</td><td align="char" char="." valign="bottom">1418 (26.3)</td><td align="char" char="." valign="bottom">3539 (26.8)</td><td align="char" char="." valign="bottom">24,812 (26.3)</td></tr><tr><td align="left" valign="bottom">Median (IQI)</td><td align="char" char="." valign="bottom">64 (57–70)</td><td align="char" char="." valign="bottom">63 (56–69)</td><td align="char" char="." valign="bottom">74 (59–75)</td><td align="char" char="." valign="bottom">63 (56–69)</td><td align="char" char="." valign="bottom">64 (57–70)</td><td align="char" char="." valign="bottom">64 (57–70)</td><td align="char" char="." valign="bottom">64 (57–70)</td></tr><tr><td align="left" valign="bottom"><bold>Ethnicity</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Danish descent</td><td align="char" char="." valign="bottom">51,287 (93.6)</td><td align="char" char="." valign="bottom">2735 (93.0)</td><td align="char" char="." valign="bottom">1221 (92.6)</td><td align="char" char="." valign="bottom">15,484 (93.1)</td><td align="char" char="." valign="bottom">4716 (92.4)</td><td align="char" char="." valign="bottom">11,344 (92.5)</td><td align="char" char="." valign="bottom">86,787 (93.3)</td></tr><tr><td align="left" valign="bottom">Western immigrant</td><td align="char" char="." valign="bottom">1306 (2.4)</td><td align="char" char="." valign="bottom">66 (2.2)</td><td align="char" char="." valign="bottom">37 (2.8)</td><td align="char" char="." valign="bottom">388 (2.3)</td><td align="char" char="." valign="bottom">130 (2.5)</td><td align="char" char="." valign="bottom">302 (2.5)</td><td align="char" char="." valign="bottom">2229 (2.4)</td></tr><tr><td align="left" valign="bottom">Non-western immigrant</td><td align="char" char="." valign="bottom">2205 (4.0)</td><td align="char" char="." valign="bottom">140 (4.8)</td><td align="char" char="." valign="bottom">61 (4.6)</td><td align="char" char="." valign="bottom">756 (4.5)</td><td align="char" char="." valign="bottom">257 (5.0)</td><td align="char" char="." valign="bottom">620 (5.1)</td><td align="char" char="." valign="bottom">4039 (4.3)</td></tr><tr><td align="left" valign="bottom"><bold>Cohabitation status</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Living alone</td><td align="char" char="." valign="bottom">16,451 (30.0)</td><td align="char" char="." valign="bottom">939 (31.9)</td><td align="char" char="." valign="bottom">463 (35.1)</td><td align="char" char="." valign="bottom">5046 (30.3)</td><td align="char" char="." valign="bottom">1578 (30.9)</td><td align="char" char="." valign="bottom">3575 (29.1)</td><td align="char" char="." valign="bottom">28,052 (30.1)</td></tr><tr><td align="left" valign="bottom">Cohabiting/co-living</td><td align="char" char="." valign="bottom">4273 (7.8)</td><td align="char" char="." valign="bottom">231 (7.9)</td><td align="char" char="." valign="bottom">88 (6.7)</td><td align="char" char="." valign="bottom">1377 (8.3)</td><td align="char" char="." valign="bottom">431 (8.4)</td><td align="char" char="." valign="bottom">1037 (8.5)</td><td align="char" char="." valign="bottom">7437 (8.0)</td></tr><tr><td align="left" valign="bottom">Married/registered partner</td><td align="char" char="." valign="bottom">34,074 (62.2)</td><td align="char" char="." valign="bottom">1771 (60.2)</td><td align="char" char="." valign="bottom">768 (58.2)</td><td align="char" char="." valign="bottom">10,205 (61.4)</td><td align="char" char="." valign="bottom">3094 (60.6)</td><td align="char" char="." valign="bottom">7654 (62.4)</td><td align="char" char="." valign="bottom">57,566 (61.9)</td></tr><tr><td align="left" valign="bottom"><bold>Educational level (ISCED</bold>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">ISCED15 levels 1–2</td><td align="char" char="." valign="bottom">27,676 (51.3)</td><td align="char" char="." valign="bottom">1577 (54.6)</td><td align="char" char="." valign="bottom">605 (46.6)</td><td align="char" char="." valign="bottom">8988 (54.9)</td><td align="char" char="." valign="bottom">2823 (53.6)</td><td align="char" char="." valign="bottom">7064 (54.4)</td><td align="char" char="." valign="bottom">48,733 (52.5)</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 3–5</td><td align="char" char="." valign="bottom">20,618 (38.2)</td><td align="char" char="." valign="bottom">1048 (36.3)</td><td align="char" char="." valign="bottom">521 (40.1)</td><td align="char" char="." valign="bottom">5741 (35.1)</td><td align="char" char="." valign="bottom">1907 (36.2)</td><td align="char" char="." valign="bottom">4682 (36.1)</td><td align="char" char="." valign="bottom">34,517 (37.2)</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 6–8</td><td align="char" char="." valign="bottom">5666 (10.5)</td><td align="char" char="." valign="bottom">264 (9.1)</td><td align="char" char="." valign="bottom">172 (13.3)</td><td align="char" char="." valign="bottom">1632 (10.0)</td><td align="char" char="." valign="bottom">540 (10.2)</td><td align="char" char="." valign="bottom">1231 (9.5)</td><td align="char" char="." valign="bottom">9505 (10.2)</td></tr><tr><td align="left" valign="bottom"><bold>Disposable income</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Lowest quintile</td><td align="char" char="." valign="bottom">11,851 (21.6)</td><td align="char" char="." valign="bottom">556 (18.9)</td><td align="char" char="." valign="bottom">321 (24.3)</td><td align="char" char="." valign="bottom">3124 (18.8)</td><td align="char" char="." valign="bottom">962 (17.9)</td><td align="char" char="." valign="bottom">2481 (18.8)</td><td align="char" char="." valign="bottom">19,295 (20.5)</td></tr><tr><td align="left" valign="bottom">Second quintile</td><td align="char" char="." valign="bottom">12,530 (22.8)</td><td align="char" char="." valign="bottom">690 (23.5)</td><td align="char" char="." valign="bottom">351 (26.6)</td><td align="char" char="." valign="bottom">3555 (21.4)</td><td align="char" char="." valign="bottom">1211 (22.5)</td><td align="char" char="." valign="bottom">2954 (22.4)</td><td align="char" char="." valign="bottom">21,291 (22.6)</td></tr><tr><td align="left" valign="bottom">Third quintile</td><td align="char" char="." valign="bottom">11,077 (20.2)</td><td align="char" char="." valign="bottom">608 (20.7)</td><td align="char" char="." valign="bottom">234 (17.7)</td><td align="char" char="." valign="bottom">3439 (20.7)</td><td align="char" char="." valign="bottom">1042 (19.4)</td><td align="char" char="." valign="bottom">2479 (18.8)</td><td align="char" char="." valign="bottom">18,879 (20.0)</td></tr><tr><td align="left" valign="bottom">Fourth quintile</td><td align="char" char="." valign="bottom">10,142 (18.5)</td><td align="char" char="." valign="bottom">569 (19.4)</td><td align="char" char="." valign="bottom">210 (15.9)</td><td align="char" char="." valign="bottom">3321 (20.0)</td><td align="char" char="." valign="bottom">1046 (19.5)</td><td align="char" char="." valign="bottom">2615 (19.9)</td><td align="char" char="." valign="bottom">17,903 (19.0)</td></tr><tr><td align="left" valign="bottom">Highest quintile</td><td align="char" char="." valign="bottom">9244 (16.9)</td><td align="char" char="." valign="bottom">517 (17.6)</td><td align="char" char="." valign="bottom">203 (15.4)</td><td align="char" char="." valign="bottom">3165 (19.1)</td><td align="char" char="." valign="bottom">1114 (20.7)</td><td align="char" char="." valign="bottom">2641 (20.1)</td><td align="char" char="." valign="bottom">16,884 (17.9)</td></tr><tr><td align="left" valign="bottom"><bold>Healthcare usage</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom"/></tr><tr><td align="left" valign="bottom">Rare</td><td align="char" char="." valign="bottom">8431 (15.4)</td><td align="char" char="." valign="bottom">409 (13.9)</td><td align="char" char="." valign="bottom">161 (12.2)</td><td align="char" char="." valign="bottom">2576 (15.5)</td><td align="char" char="." valign="bottom">770 (14.3)</td><td align="char" char="." valign="bottom">1903 (14.4)</td><td align="char" char="." valign="bottom">14,250 (15.1)</td></tr><tr><td align="left" valign="bottom">Low</td><td align="char" char="." valign="bottom">8450 (15.4)</td><td align="char" char="." valign="bottom">440 (15.0)</td><td align="char" char="." valign="bottom">171 (13.0)</td><td align="char" char="." valign="bottom">2628 (15.8)</td><td align="char" char="." valign="bottom">833 (15.5)</td><td align="char" char="." valign="bottom">1957 (14.8)</td><td align="char" char="." valign="bottom">14,479 (15.3)</td></tr><tr><td align="left" valign="bottom">Average</td><td align="char" char="." valign="bottom">11,964 (21.8)</td><td align="char" char="." valign="bottom">608 (20.7)</td><td align="char" char="." valign="bottom">260 (19.7)</td><td align="char" char="." valign="bottom">3704 (22.3)</td><td align="char" char="." valign="bottom">1205 (22.4)</td><td align="char" char="." valign="bottom">2823 (21.4)</td><td align="char" char="." valign="bottom">20,564 (21.8)</td></tr><tr><td align="left" valign="bottom">High</td><td align="char" char="." valign="bottom">11,300 (20.6)</td><td align="char" char="." valign="bottom">673 (22.9)</td><td align="char" char="." valign="bottom">269 (20.4)</td><td align="char" char="." valign="bottom">3502 (21.1)</td><td align="char" char="." valign="bottom">1126 (20.9)</td><td align="char" char="." valign="bottom">2921 (22.1)</td><td align="char" char="." valign="bottom">19,791 (21.0)</td></tr><tr><td align="left" valign="bottom">Frequent</td><td align="char" char="." valign="bottom">14,741 (26.9)</td><td align="char" char="." valign="bottom">812 (27.6)</td><td align="char" char="." valign="bottom">458 (34.7)</td><td align="char" char="." valign="bottom">4218 (25.4)</td><td align="char" char="." valign="bottom">1449 (26.9)</td><td align="char" char="." valign="bottom">3611 (27.3)</td><td align="char" char="." valign="bottom">25,289 (26.8)</td></tr><tr><td align="left" valign="bottom"><bold>Time from positive FIT to colonoscopy, median (IDI</bold>)</td><td align="char" char="." valign="bottom">13 (8–29)</td><td align="char" char="." valign="bottom">13 (7–31)</td><td align="char" char="." valign="bottom">13 (8–31)</td><td align="char" char="." valign="bottom">13 (8–29)</td><td align="char" char="." valign="bottom">13 (8–28)</td><td align="char" char="." valign="bottom">13 (8–29)</td><td align="char" char="." valign="bottom">13 (8–29)</td></tr></tbody></table><table-wrap-foot><fn><p>IQI = interquartile interval.; IDI = interdecentile interval.; ISCED = International Standard Classification of Education.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-4"><title>Compliance with colonoscopy during the COVID-19 pandemic</title><p>There were 94,373 positive FIT tests (in 92,848 individuals) during the study period. Among those 53.7% were men, the median age was 65 years old (IQI=57–70) and 93.3% were of Danish descent (<xref ref-type="table" rid="table3">Table 3</xref>). Before the pandemic, 89.9% had a colonoscopy performed within 60 days since a positive FIT test (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The results were unchanged when extending the length of follow-up time to 365 days (data not shown). A minor reduction in compliance with colonoscopy within 60 days was seen during first lockdown (<xref ref-type="fig" rid="fig4">Figure 4</xref>) reflected in a PR of 0.96 (95% CI: 0.93–0.98) (<xref ref-type="table" rid="table4">Table 4</xref>). The reduction corresponded to a compliance rate of 85.2% (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). The compliance remained stable throughout the rest of the study period (<xref ref-type="table" rid="table4">Table 4</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Compliance with colonoscopy (%) within 60 and 365 days since a positive FIT test from colorectal cancer screening in Denmark from 2018 to 2021.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81808-fig4-v2.tif"/></fig><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Prevalence ratios (PRs) and 95% confidence intervals (CIs) of compliance with colonoscopy within 60 days since a positive FIT test from colorectal cancer screening in Denmark from 2018 to 2021<xref ref-type="table-fn" rid="table4fn1"><sup>*</sup></xref>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="3"/><th align="left" valign="bottom" rowspan="3">N</th><th align="left" valign="bottom" colspan="2">Pre-pandemic (1 January 2018 to 31 January 2020)</th><th align="left" valign="bottom" colspan="2">Pre-lockdown (1 February 2020 to 10 March 2020)</th><th align="left" valign="bottom" colspan="2">1st lockdown (11 March 2020 to 15 April 2020)</th><th align="left" valign="bottom" colspan="2">1st re-opening (16 April 2020 to 15 December 2020)</th><th align="left" valign="bottom" colspan="2">2nd lockdown (16 December 2020 to 27 February 2021)</th><th align="left" valign="bottom" colspan="2">2nd re-opening (28 February 2021 to 30 September 2021)</th></tr><tr><th align="left" valign="bottom" colspan="2">N=54,982</th><th align="left" valign="bottom" colspan="2">N=2944</th><th align="left" valign="bottom" colspan="2">N=1319</th><th align="left" valign="bottom" colspan="2">N=16,628</th><th align="left" valign="bottom" colspan="2">N=5390</th><th align="left" valign="bottom" colspan="2">N=13,222</th></tr><tr><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th><th align="left" valign="bottom">PR</th><th align="char" char="." valign="bottom">[95% CI]</th></tr></thead><tbody><tr><td align="left" valign="bottom"><bold>Overall</bold></td><td align="char" char="." valign="bottom">94,373</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.93–0.98]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–1.00]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[1.00–1.03]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–1.01]</td></tr><tr><td align="left" valign="bottom"><bold>Sex</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Men</td><td align="char" char="." valign="bottom">50,665</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.95–0.99]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.91–0.97]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–0.99]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.00]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.96–0.98]</td></tr><tr><td align="left" valign="bottom">Women</td><td align="char" char="." valign="bottom">43,708</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.93–0.99]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–1.00]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.99–1.02]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–1.00]</td></tr><tr><td align="left" valign="bottom"><bold>Age at invitation</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="char" char="." valign="bottom">50–54 years</td><td align="char" char="." valign="bottom">16,435</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.00–1.08]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.93–1.04]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.03]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.97–1.05]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.94–1.01]</td></tr><tr><td align="char" char="." valign="bottom">55–59 years</td><td align="char" char="." valign="bottom">15,429</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.94–1.01]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.87–1.01]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.02]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.98–1.05]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.98–1.06]</td></tr><tr><td align="char" char="." valign="bottom">60–64 years</td><td align="char" char="." valign="bottom">17,322</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.04]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[0.98–1.11]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.01]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.04]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.94–1.01]</td></tr><tr><td align="char" char="." valign="bottom">65–69 years</td><td align="char" char="." valign="bottom">20,375</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.03]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[0.98–1.10]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.01]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[1.00–1.06]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.03]</td></tr><tr><td align="char" char="." valign="bottom">70–74 years</td><td align="char" char="." valign="bottom">24,812</td><td align="char" char="." valign="bottom">2.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.91–0.98]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.90–0.97]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.04]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.02]</td></tr><tr><td align="left" valign="bottom"><bold>Ethnicity</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Danish descent</td><td align="char" char="." valign="bottom">86,787</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.00]</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.94–0.99]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.99–1.01]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[1.00–1.03]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.01]</td></tr><tr><td align="left" valign="bottom">Western immigrant</td><td align="char" char="." valign="bottom">2229</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">[0.75–1.02]</td><td align="char" char="." valign="bottom">0.84</td><td align="char" char="." valign="bottom">[0.68–1.04]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.90–1.05]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.87–1.13]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.89–1.11]</td></tr><tr><td align="left" valign="bottom">Non-western immigrant</td><td align="char" char="." valign="bottom">4039</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">[0.82–1.01]</td><td align="char" char="." valign="bottom">0.90</td><td align="char" char="." valign="bottom">[0.78–1.05]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.92–1.04]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.92–1.10]</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.87–1.04]</td></tr><tr><td align="left" valign="bottom"><bold>Cohabitation status</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Living alone</td><td align="char" char="." valign="bottom">28,052</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.93–1.00]</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.90–1.00]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.02]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.01–1.08]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.01–1.08]</td></tr><tr><td align="left" valign="bottom">Cohabiting/co-living</td><td align="char" char="." valign="bottom">7437</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.96–1.08]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.93–1.09]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.05]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[0.98–1.08]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[0.98–1.08]</td></tr><tr><td align="left" valign="bottom">Married/registered partner</td><td align="char" char="." valign="bottom">57,566</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.00]</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.93–0.99]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.98–1.00]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.02]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.02]</td></tr><tr><td align="left" valign="bottom"><bold>Educational level (ISCED</bold>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">ISCED15 levels 1–2</td><td align="char" char="." valign="bottom">48,733</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.02]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.91–0.98]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.00]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.99–1.03]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 3–5</td><td align="char" char="." valign="bottom">34517</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.95–1.00]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.94–1.01]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.99–1.02]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.99–1.04]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.03]</td></tr><tr><td align="left" valign="bottom">ISCED15 levels 6–8</td><td align="char" char="." valign="bottom">9505</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.89–1.00]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.91–1.03]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.02]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.98–1.07]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.94–1.03]</td></tr><tr><td align="left" valign="bottom"><bold>Disposable income</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Lowest quintile</td><td align="char" char="." valign="bottom">19,295</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.92–1.00]</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">[0.86–0.96]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.01]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.98–1.06]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.95–1.02]</td></tr><tr><td align="left" valign="bottom">Second quintile</td><td align="char" char="." valign="bottom">21,291</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.94–1.02]</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">[0.87–0.98]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.99–1.04]</td><td align="char" char="." valign="bottom">1.04</td><td align="char" char="." valign="bottom">[1.01–1.08]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.99–1.06]</td></tr><tr><td align="left" valign="bottom">Third quintile</td><td align="char" char="." valign="bottom">18,879</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.95–1.02]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.93–1.03]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.00]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.03]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.02]</td></tr><tr><td align="left" valign="bottom">Fourth quintile</td><td align="char" char="." valign="bottom">17,903</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.94–1.00]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.93–1.02]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.01]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.03]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.95–1.01]</td></tr><tr><td align="left" valign="bottom">Highest quintile</td><td align="char" char="." valign="bottom">16,884</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.05]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.97–1.06]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.01]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.97–1.03]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.95–1.00]</td></tr><tr><td align="left" valign="bottom"><bold>Healthcare usage</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Rare</td><td align="char" char="." valign="bottom">14,250</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.94–1.02]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.92–1.04]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.99–1.04]</td><td align="char" char="." valign="bottom">1.03</td><td align="char" char="." valign="bottom">[0.99–1.07]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.03]</td></tr><tr><td align="left" valign="bottom">Low</td><td align="char" char="." valign="bottom">14,479</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.93–1.01]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.92–1.03]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.97–1.02]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.95–1.02]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.95–1.01]</td></tr><tr><td align="left" valign="bottom">Average</td><td align="char" char="." valign="bottom">20,564</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.04]</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">[0.89–0.99]</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">[0.98–1.02]</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">[0.99–1.05]</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.96–1.02]</td></tr><tr><td align="left" valign="bottom">High</td><td align="char" char="." valign="bottom">19,791</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.99</td><td align="char" char="." valign="bottom">[0.95–1.02]</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">[0.92–1.01]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.01]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.97–1.04]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.97–1.04]</td></tr><tr><td align="left" valign="bottom">Frequent</td><td align="char" char="." valign="bottom">25,289</td><td align="char" char="." valign="bottom">1.00</td><td align="left" valign="bottom">–</td><td align="char" char="." valign="bottom">0.96</td><td align="char" char="." valign="bottom">[0.93–1.00]</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">[0.90–0.99]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.96–1.01]</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">[0.98–1.04]</td><td align="char" char="." valign="bottom">0.98</td><td align="char" char="." valign="bottom">[0.95–1.01]</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><label>*</label><p>Adjusted for year, month and age at invitation; PR = prevalence ratio; CI = confidence interval; ISCED = International Standard Classification of Education.</p></fn></table-wrap-foot></table-wrap><p>Immigrants, individuals living alone and individuals with a low income had a lower compliance with colonoscopy before the pandemic (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). During pre-lockdown and first lockdown, the compliance with colonoscopy within 60 days was lower among both 55–59 and 70–74 years old, among immigrants and among individuals with a low income compared with the previous years (<xref ref-type="table" rid="table4">Table 4</xref>). The results were unchanged when extending the length of follow-up time to 365 days (data not shown).</p></sec><sec id="s3-5"><title>Time to participation</title><p>Before the pandemic, the median time from invitation to participation was 28 days (IDI = 16–72) increasing to 32 days (IDI = 16–64) during first lockdown and returning to 28 days during first re-opening (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3-6"><title>Sensitivity analysis</title><p>When conducting a sensitivity analysis accounting for the reduction in the number of invitations in weeks 11–14 2020, the estimates were almost identical (data not shown).</p></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Main findings</title><p>In this nationwide population-based study comprising more than 3.1 million invitations (in 1,928,725 individuals), we found that 60.7% participated in colorectal cancer screening within 90 days before the pandemic. A minor reduction in participation was observed at the start of the pandemic corresponding to a participation rate of 54.9% during pre-lockdown and 53.0% during first lockdown. From the first re-opening of the society and onwards, a relative 5–10% increased participation in screening was seen corresponding to a participation rate of up to 64.9%. The largest relative increase in participation was observed among 55–59 years old and among immigrants. Among 94,373 positive FIT tests (in 92,848 individuals), we saw that the compliance with colonoscopy within 60 days was 89.9% before the pandemic. A slight reduction was observed during first lockdown, where after it resumed to normal levels.</p></sec><sec id="s4-2"><title>Comparison with previous studies</title><p>In most of the world, the colorectal cancer screening programmes were paused at the start of the pandemic (<xref ref-type="bibr" rid="bib11">Morris et al., 2021</xref>; <xref ref-type="bibr" rid="bib3">Dinmohamed et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Kortlever et al., 2021</xref>; <xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Walker et al., 2021</xref>), while Denmark was one of the only countries to have the programme running throughout the pandemic. The situation in Denmark is therefore unique and resembles ‘a natural experiment’ illustrating what happens if a screening programme based on faecal samples obtained at home is kept open during a pandemic.</p><p>In Catalonia in Spain, the colorectal cancer screening programme was paused for the first 7 months of the pandemic leading to a reduced participation in stool-based screening (5.1% reduction) and an increased proportion of advanced-stage cancers (stages III–IV) (13% increase) (<xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref>). The screening programme in Catalonia in Spain (<xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref>) requires the invitees to collect a FIT test kit at a pharmacy, which might be an additional barrier to participation in particular during a pandemic. The programme in Denmark is on the contrary based on a home-based test mailed directly to the invitees. Also in England, the colorectal cancer screening programme based on faecal samples was paused at the start of the pandemic, which led to large reductions in the number of people referred for suspected cancer (63% relative reduction), diagnosed (22% relative reduction) and receiving surgery for colorectal cancer (31% relative reduction) in April 2020 (<xref ref-type="bibr" rid="bib11">Morris et al., 2021</xref>). In the Netherlands, the colorectal cancer screening programme was temporarily halted at the start of the pandemic resulting in a lower participation in FIT screening (5% and 7% reduction in February and March 2020, respectively) and fewer colorectal cancers diagnosed (<xref ref-type="bibr" rid="bib3">Dinmohamed et al., 2020</xref>). In Canada, the FIT-based screening programme was suspended at the start of the pandemic resulting in a large reduction in the colorectal cancer faecal test volume (90% reduction in May 2020) (<xref ref-type="bibr" rid="bib28">Walker et al., 2021</xref>). We found a minor reduction in participation at the start of the pandemic corresponding to a participation rate of 54.9% during pre-lockdown and 53.0% during first lockdown indicating that a few people do not participate at the very early phase of a pandemic. These results did not differ when extending the length of follow-up time.</p><p>The study from Catalonia in Spain <xref ref-type="bibr" rid="bib27">Vives et al., 2022</xref> found a reduction in participation in subsequent colonoscopy (8.9% reduction) as a result of the screening programme being closed during the first 7 months of the pandemic. The study from England also showed a marked reduction in the number of colonoscopies (92% relative reduction) (<xref ref-type="bibr" rid="bib11">Morris et al., 2021</xref>) as a result of the screening programme being paused at the start of the pandemic. The study from the Netherlands showed a reduced participation in follow-up colonoscopy in the months before and during the suspension of the FIT screening programme (<xref ref-type="bibr" rid="bib8">Kortlever et al., 2021</xref>). The suspension of the colorectal cancer screening programme in Canada led to a 99% reduction of colonoscopies performed in April 2020 (<xref ref-type="bibr" rid="bib28">Walker et al., 2021</xref>). We found a 4% reduction in compliance with colonoscopy within 60 days during first lockdown despite the programme being open. Fortunately, the compliance with colonoscopy resumed to the same level as before the pandemic from first re-opening and onwards. Congruently, a qualitative study from the United Kingdom <xref ref-type="bibr" rid="bib29">Wilson et al., 2021</xref> found that interview participants were concerned about visiting healthcare settings at the start of the pandemic, which could explain the slightly lower compliance with colonoscopy.</p><p>The potential downstream effect of a reduced or increased participation in colorectal cancer screening during the pandemic on subsequent colorectal cancer diagnoses and deaths are important aspects to take into account. A Danish study by Skovlund et al. found a 24% reduction in the number of colon cancers diagnosed from April to June 2020 in Denmark (<xref ref-type="bibr" rid="bib18">Skovlund et al., 2022</xref>) which is most likely an overestimation due to a delayed registration of cancers at the time of the study by Skovlund et al. In a more recent study by Weinberger et al. using data from the Danish Colorectal Cancer Database (<xref ref-type="bibr" rid="bib6">Ingeholm et al., 2016</xref>), we have shown a drop in the number of colorectal cancers detected during first lockdown; however, only a minor reduction (7%) of colorectal cancers in 2020 as compared to the previous years (Weinberger et al., under review). This reduction may be caused either by a reduced participation in colorectal cancer screening, a change in health-seeking behaviour with fever referred to colonoscopy after symptoms or a reduction of coincidental detections of colorectal cancers as a result of elective surveillance colonoscopy being cancelled or postponed. Thus in the study by Weinberger et al. (under review), we found a reduction in the proportion of colorectal cancers detected via screening (16.9% vs. 21.8%; PR = 0.79; 95%CI: 0.73–0.86) during the pandemic. Furthermore, we observed a slight increase in the proportion of stage I tumours (25.0% vs. 23.4%; PR = 1.07; 95%CI: 1.00–1.15); however, the risk of death within 90days since operation was unchanged (3.9% vs. 3.6%; PR = 1.02; 95%CI: 0.84–1.23) during the pandemic compared with the previous years (Weinberger et al., under review). These results are thus based on a setting where FIT-based colorectal cancer screening and early detection of cancer in general continued throughout the pandemic. Modelling studies from other countries have shown that short-term disruptions to colorectal cancer screening during the pandemic would have a marked impact on colorectal cancer incidence and deaths from 2020 to 2050 because of missed screening (<xref ref-type="bibr" rid="bib2">de Jonge et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Mandrik et al., 2022</xref>). Where possible, it is thus important to keep the FIT-based colorectal cancer screening programme running throughout a pandemic or a similar health crisis. Furthermore, catch-up screening should be provided in settings where the colorectal cancer screening programme was disrupted to mitigate the impact on subsequent colorectal cancer deaths (<xref ref-type="bibr" rid="bib2">de Jonge et al., 2021</xref>).</p></sec><sec id="s4-3"><title>Socio-economic differences</title><p>In line with previous studies (<xref ref-type="bibr" rid="bib9">Larsen et al., 2017</xref>–<xref ref-type="bibr" rid="bib14">Pallesen et al., 2021</xref>), we found that the participation in colorectal cancer screening in general was lowest among the youngest age group, among men, among immigrants, among individuals living alone or cohabiting, among individuals with a low educational level, a low income and among individuals who rarely use the healthcare system.</p><p>We found an overall 5–10% increased participation in screening from first re-opening and onwards. The largest increases in participation was observed among individuals aged 55–59 years old and among immigrants. The reason for the increased participation among individuals aged 55–59 years old is unknown. A qualitative study from Denmark found that immigrants generally have a mistrust in the Danish healthcare system and, for example, prefer a second opinion in their native country (<xref ref-type="bibr" rid="bib23">Tatari et al., 2020</xref>). However, during the pandemic immigrants may not have been able to travel to their home country and may therefore have opted to participate in screening in Denmark instead of in their home-country.</p></sec><sec id="s4-4"><title>Strengths and limitations</title><p>We used high-quality population-based data covering the Danish population invited to participate in colorectal cancer screening, which is a major strength of the study. The completeness of the Danish registries is high (<xref ref-type="bibr" rid="bib26">Thygesen et al., 2011</xref>), which also confers to the Danish Colorectal Cancer Screening Database (<xref ref-type="bibr" rid="bib24">Thomsen et al., 2017</xref>).</p><p>Limitations of the study should also be acknowledged. We did not have data on underlying disease, which may affect individuals’ participation in colorectal cancer screening and compliance with colonoscopy. We did; however, include age which is strongly associated with the level of comorbidity and we thereby reduce the theoretical impact of comorbidity on the results. Additionally, we did not have data on COVID-19 vaccination status, which may affect colorectal cancer screening participation and compliance with colonoscopy.</p></sec><sec id="s4-5"><title>Implications</title><p>The initial colorectal cancer screening test is a home-based self-collected sample and does thereby not require contact with the healthcare system—or use of, for example, public transport to reach a healthcare facility. In theory, this screening modality should be little affected by the pandemic; nonetheless, a slight reduction in participation was observed at the start of the pandemic perhaps because people counterbalance the importance of screening participation amidst a pandemic as seen in other screening programmes (<xref ref-type="bibr" rid="bib7">Kirkegaard et al., 2021</xref>). It is therefore important to ensure that the health communication is clear and that people are made aware that the colorectal cancer screening programme is open and that people have the possibility to participate in both the initial screening test and in the subsequent colonoscopy.</p><p>We found an overall 5–10% increased participation in colorectal cancer screening from first re-opening and onwards. We did not find an increased participation in the other cancer screening programmes (breast and cervical cancer) in Denmark (<xref ref-type="bibr" rid="bib13">Olesen et al., 2023</xref>; <xref ref-type="bibr" rid="bib12">Olesen et al., 2022</xref>) most likely because those programmes require contact with the healthcare system. A home-based self-collected screening sample thus appear to work well during a pandemic, which could be used in other programmes, for example, cervical cancer screening.</p><p>The overall compliance with colonoscopy was largely unaffected by the pandemic, which gives reassurance that individuals in need of follow-up because of a positive FIT test do attend colonoscopy amidst a pandemic. Nonetheless, we found that the compliance with colonoscopy was reduced among 55–59 years , 70–74 years old, among immigrants and among persons with a low income indicating that some groups are affected adversely by the pandemic. Worryingly, some cancers may have gone undetected or diagnosed at a later stage in these groups of individuals.</p></sec><sec id="s4-6"><title>Conclusion</title><p>In this nationwide study, we found that the participation in the Danish FIT-based colorectal cancer screening programme and subsequent compliance to colonoscopy after a positive FIT test was only slightly affected by the COVID-19 pandemic.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Funding acquisition, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Funding acquisition, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Ethical considerations The study is registered at the Central Denmark Region's register of research projects (journal number 1-16-02-381-20). Patient consent is not required by Danish law for register-based studies.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Participation in colorectal cancer screening (%) in Denmark within 90 days since invitation from 2018–2021.</title></caption><media xlink:href="elife-81808-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Baseline characteristics of first-time invitees invited to participate in colorectal cancer screening in Denmark 2018–2021.</title></caption><media xlink:href="elife-81808-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Prevalence ratios (PRs) and 95% confidence intervals (CI) of participation in colorectal cancer screening within 90 days since invitation in Denmark among first-time invitees 2018–2021.</title></caption><media xlink:href="elife-81808-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Compliance with colonoscopy (%) in Denmark within 60 days since a positive FIT test from 2018 to 2021.</title></caption><media xlink:href="elife-81808-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-81808-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>In order to comply with the Danish regulations on data privacy, the datasets generated and analysed during this project are not publicly available as the data are stored and maintained electronically at Statistics Denmark, where it only can be accessed by pre-approved researchers using a secure VPN remote access. Furthermore, no data at a personal level nor data not exclusively necessary for publication are allowed to be extracted from the secure data environment at Statistics Denmark. Access to the data can however be granted by the authors of the present study upon a reasonable scientific proposal within the boundaries of the present project and for scientific purposes only.</p></sec><ack id="ack"><title>Acknowledgements</title><p>The study was funded by the Danish Cancer Society Scientific Committee (Grant number R321-A17417) and the Danish regions.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>JS</given-names></name><name><surname>Olivarius</surname><given-names>NDF</given-names></name><name><surname>Krasnik</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The danish national health service register</article-title><source>Scandinavian Journal of Public Health</source><volume>39</volume><fpage>34</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1177/1403494810394718</pub-id><pub-id pub-id-type="pmid">21775348</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jonge</surname><given-names>L</given-names></name><name><surname>Worthington</surname><given-names>J</given-names></name><name><surname>van Wifferen</surname><given-names>F</given-names></name><name><surname>Iragorri</surname><given-names>N</given-names></name><name><surname>Peterse</surname><given-names>EFP</given-names></name><name><surname>Lew</surname><given-names>J-B</given-names></name><name><surname>Greuter</surname><given-names>MJE</given-names></name><name><surname>Smith</surname><given-names>HA</given-names></name><name><surname>Feletto</surname><given-names>E</given-names></name><name><surname>Yong</surname><given-names>JHE</given-names></name><name><surname>Canfell</surname><given-names>K</given-names></name><name><surname>Coupé</surname><given-names>VMH</given-names></name><name><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name><collab>COVID-19 and Cancer Global Modelling Consortium working group 2</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study</article-title><source>The Lancet. Gastroenterology &amp; Hepatology</source><volume>6</volume><fpage>304</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(21)00003-0</pub-id><pub-id pub-id-type="pmid">33548185</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinmohamed</surname><given-names>AG</given-names></name><name><surname>Cellamare</surname><given-names>M</given-names></name><name><surname>Visser</surname><given-names>O</given-names></name><name><surname>de Munck</surname><given-names>L</given-names></name><name><surname>Elferink</surname><given-names>MAG</given-names></name><name><surname>Westenend</surname><given-names>PJ</given-names></name><name><surname>Wesseling</surname><given-names>J</given-names></name><name><surname>Broeders</surname><given-names>MJM</given-names></name><name><surname>Kuipers</surname><given-names>EJ</given-names></name><name><surname>Merkx</surname><given-names>MAW</given-names></name><name><surname>Nagtegaal</surname><given-names>ID</given-names></name><name><surname>Siesling</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the netherlands</article-title><source>Journal of Hematology &amp; Oncology</source><volume>13</volume><elocation-id>147</elocation-id><pub-id pub-id-type="doi">10.1186/s13045-020-00984-1</pub-id><pub-id pub-id-type="pmid">33148289</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garborg</surname><given-names>K</given-names></name><name><surname>Holme</surname><given-names>Ø</given-names></name><name><surname>Løberg</surname><given-names>M</given-names></name><name><surname>Kalager</surname><given-names>M</given-names></name><name><surname>Adami</surname><given-names>HO</given-names></name><name><surname>Bretthauer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Current status of screening for colorectal cancer</article-title><source>Annals of Oncology</source><volume>24</volume><fpage>1963</fpage><lpage>1972</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdt157</pub-id><pub-id pub-id-type="pmid">23619033</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitson</surname><given-names>P</given-names></name><name><surname>Glasziou</surname><given-names>P</given-names></name><name><surname>Watson</surname><given-names>E</given-names></name><name><surname>Towler</surname><given-names>B</given-names></name><name><surname>Irwig</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update</article-title><source>The American Journal of Gastroenterology</source><volume>103</volume><fpage>1541</fpage><lpage>1549</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2008.01875.x</pub-id><pub-id pub-id-type="pmid">18479499</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingeholm</surname><given-names>P</given-names></name><name><surname>Gögenur</surname><given-names>I</given-names></name><name><surname>Iversen</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Danish colorectal cancer group database</article-title><source>Clinical Epidemiology</source><volume>8</volume><fpage>465</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S99481</pub-id><pub-id pub-id-type="pmid">27822086</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkegaard</surname><given-names>P</given-names></name><name><surname>Edwards</surname><given-names>A</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Balancing risks: qualitative study of attitudes, motivations and intentions about attending for mammography during the COVID-19 pandemic</article-title><source>Scandinavian Journal of Public Health</source><volume>49</volume><fpage>700</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1177/14034948211002648</pub-id><pub-id pub-id-type="pmid">33764227</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kortlever</surname><given-names>TL</given-names></name><name><surname>de Jonge</surname><given-names>L</given-names></name><name><surname>Wisse</surname><given-names>PHA</given-names></name><name><surname>Seriese</surname><given-names>I</given-names></name><name><surname>Otto-Terlouw</surname><given-names>P</given-names></name><name><surname>van Leerdam</surname><given-names>ME</given-names></name><name><surname>Spaander</surname><given-names>MCW</given-names></name><name><surname>Dekker</surname><given-names>E</given-names></name><name><surname>Lansdorp-Vogelaar</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The national FIT-based colorectal cancer screening program in the netherlands during the COVID-19 pandemic</article-title><source>Preventive Medicine</source><volume>151</volume><elocation-id>106643</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106643</pub-id><pub-id pub-id-type="pmid">34217421</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>MB</given-names></name><name><surname>Mikkelsen</surname><given-names>EM</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>Friis-Hansen</surname><given-names>L</given-names></name><name><surname>Ovesen</surname><given-names>AU</given-names></name><name><surname>Rahr</surname><given-names>HB</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sociodemographic characteristics of nonparticipants in the danish colorectal cancer screening program: a nationwide cross-sectional study</article-title><source>Clinical Epidemiology</source><volume>9</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S139168</pub-id><pub-id pub-id-type="pmid">28721099</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandrik</surname><given-names>O</given-names></name><name><surname>Chilcott</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in england: a decision analysis to prepare for future screening disruption</article-title><source>Preventive Medicine</source><volume>160</volume><elocation-id>107076</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2022.107076</pub-id><pub-id pub-id-type="pmid">35526674</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>EJA</given-names></name><name><surname>Goldacre</surname><given-names>R</given-names></name><name><surname>Spata</surname><given-names>E</given-names></name><name><surname>Mafham</surname><given-names>M</given-names></name><name><surname>Finan</surname><given-names>PJ</given-names></name><name><surname>Shelton</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>M</given-names></name><name><surname>Spencer</surname><given-names>K</given-names></name><name><surname>Emberson</surname><given-names>J</given-names></name><name><surname>Hollings</surname><given-names>S</given-names></name><name><surname>Curnow</surname><given-names>P</given-names></name><name><surname>Gair</surname><given-names>D</given-names></name><name><surname>Sebag-Montefiore</surname><given-names>D</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>Rutter</surname><given-names>MD</given-names></name><name><surname>Nicholson</surname><given-names>BD</given-names></name><name><surname>Rashbass</surname><given-names>J</given-names></name><name><surname>Landray</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Casadei</surname><given-names>B</given-names></name><name><surname>Baigent</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study</article-title><source>The Lancet. Gastroenterology &amp; Hepatology</source><volume>6</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(21)00005-4</pub-id><pub-id pub-id-type="pmid">33453763</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>TB</given-names></name><name><surname>Jensen</surname><given-names>H</given-names></name><name><surname>Møller</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>JW</given-names></name><name><surname>Waldstrøm</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Participation in the Nation-Wide Cervical Cancer Screening Programme in Denmark during the COVID-19 Pandemic: An Observational Study</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2022.08.17.22278655</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olesen</surname><given-names>TB</given-names></name><name><surname>Jensen</surname><given-names>H</given-names></name><name><surname>Møller</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>JW</given-names></name><name><surname>Waldstrøm</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Participation in the nationwide cervical cancer screening programme in denmark during the COVID-19 pandemic: an observational study</article-title><source>eLife</source><volume>12</volume><elocation-id>e81522</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.81522</pub-id><pub-id pub-id-type="pmid">36661213</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallesen</surname><given-names>AVJ</given-names></name><name><surname>Herrstedt</surname><given-names>J</given-names></name><name><surname>Westendorp</surname><given-names>RGJ</given-names></name><name><surname>Mortensen</surname><given-names>LH</given-names></name><name><surname>Kristiansen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Differential effects of colorectal cancer screening across sociodemographic groups in denmark: a register-based study</article-title><source>Acta Oncologica</source><volume>60</volume><fpage>323</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1080/0284186X.2020.1869829</pub-id><pub-id pub-id-type="pmid">33427545</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pottegård</surname><given-names>A</given-names></name><name><surname>Kristensen</surname><given-names>KB</given-names></name><name><surname>Reilev</surname><given-names>M</given-names></name><name><surname>Lund</surname><given-names>LC</given-names></name><name><surname>Ernst</surname><given-names>MT</given-names></name><name><surname>Hallas</surname><given-names>J</given-names></name><name><surname>Thomsen</surname><given-names>RW</given-names></name><name><surname>Christiansen</surname><given-names>CF</given-names></name><name><surname>Sørensen</surname><given-names>HT</given-names></name><name><surname>Johansen</surname><given-names>NB</given-names></name><name><surname>Støvring</surname><given-names>H</given-names></name><name><surname>Christensen</surname><given-names>S</given-names></name><name><surname>Kragh Thomsen</surname><given-names>M</given-names></name><name><surname>Husby</surname><given-names>A</given-names></name><name><surname>Voldstedlund</surname><given-names>M</given-names></name><name><surname>Kjær</surname><given-names>J</given-names></name><name><surname>Brun</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Existing data sources in clinical epidemiology: the Danish COVID-19 cohort</article-title><source>Clinical Epidemiology</source><volume>12</volume><fpage>875</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S257519</pub-id><pub-id pub-id-type="pmid">32848476</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>L</given-names></name><name><surname>Sørensen</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The Danish civil registration system as a tool in epidemiology</article-title><source>European Journal of Epidemiology</source><volume>29</volume><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1007/s10654-014-9930-3</pub-id><pub-id pub-id-type="pmid">24965263</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>SAJ</given-names></name><name><surname>Adelborg</surname><given-names>K</given-names></name><name><surname>Sundbøll</surname><given-names>J</given-names></name><name><surname>Laugesen</surname><given-names>K</given-names></name><name><surname>Ehrenstein</surname><given-names>V</given-names></name><name><surname>Sørensen</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The danish health care system and epidemiological research: from health care contacts to database records</article-title><source>Clinical Epidemiology</source><volume>11</volume><fpage>563</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S179083</pub-id><pub-id pub-id-type="pmid">31372058</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skovlund</surname><given-names>CW</given-names></name><name><surname>Friis</surname><given-names>S</given-names></name><name><surname>Christensen</surname><given-names>J</given-names></name><name><surname>Nilbert</surname><given-names>MC</given-names></name><name><surname>Mørch</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Drop in cancer diagnosis during the COVID-19 pandemic in denmark: assessment of impact during 2020</article-title><source>Acta Oncologica</source><volume>61</volume><fpage>658</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1080/0284186X.2021.2024879</pub-id><pub-id pub-id-type="pmid">35020549</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Statens Serum Institut</collab></person-group><year iso-8601-date="2021">2021a</year><article-title>Overvågningdata for covid-19 i Danmark og Europa</article-title><ext-link ext-link-type="uri" xlink:href="https://covid19.ssi.dk/overvagningsdata">https://covid19.ssi.dk/overvagningsdata</ext-link><date-in-citation iso-8601-date="2021-01-17">January 17, 2021</date-in-citation></element-citation></ref><ref id="bib20"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Statens Serum Institut</collab></person-group><year iso-8601-date="2021">2021b</year><article-title>Vaccination mod covid-19</article-title><ext-link ext-link-type="uri" xlink:href="https://covid19.ssi.dk/vaccination">https://covid19.ssi.dk/vaccination</ext-link><date-in-citation iso-8601-date="2021-01-17">January 17, 2021</date-in-citation></element-citation></ref><ref id="bib21"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Statistics Denmark</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Statistics Denmark</article-title><ext-link ext-link-type="uri" xlink:href="https://www.dst.dk/en">https://www.dst.dk/en</ext-link><date-in-citation iso-8601-date="2021-01-15">January 15, 2021</date-in-citation></element-citation></ref><ref id="bib22"><element-citation publication-type="web"><person-group person-group-type="author"><collab>Sundhedsstyrelsen</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Vaccinations-kalender</article-title><ext-link ext-link-type="uri" xlink:href="https://www.sst.dk/da/udgivelser/2021/vaccinationskalender">https://www.sst.dk/da/udgivelser/2021/vaccinationskalender</ext-link><date-in-citation iso-8601-date="2021-01-15">January 15, 2021</date-in-citation></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatari</surname><given-names>CR</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name><name><surname>Brogaard</surname><given-names>T</given-names></name><name><surname>Badre-Esfahani</surname><given-names>SK</given-names></name><name><surname>Jaafar</surname><given-names>N</given-names></name><name><surname>Kirkegaard</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Perceptions about cancer and barriers towards cancer screening among ethnic minority women in a deprived area in Denmark-a qualitative study</article-title><source>BMC Public Health</source><volume>20</volume><elocation-id>921</elocation-id><pub-id pub-id-type="doi">10.1186/s12889-020-09037-1</pub-id><pub-id pub-id-type="pmid">32532227</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>MK</given-names></name><name><surname>Njor</surname><given-names>SH</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>Linnemann</surname><given-names>D</given-names></name><name><surname>Andersen</surname><given-names>B</given-names></name><name><surname>Baatrup</surname><given-names>G</given-names></name><name><surname>Friis-Hansen</surname><given-names>LJ</given-names></name><name><surname>Jørgensen</surname><given-names>JCR</given-names></name><name><surname>Mikkelsen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Validity of data in the Danish colorectal cancer screening database</article-title><source>Clinical Epidemiology</source><volume>9</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S124454</pub-id><pub-id pub-id-type="pmid">28255255</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>MK</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>Njor</surname><given-names>SH</given-names></name><name><surname>Mikkelsen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Demographic and comorbidity predictors of adherence to diagnostic colonoscopy in the Danish colorectal cancer screening program: a nationwide cross-sectional study</article-title><source>Clinical Epidemiology</source><volume>10</volume><fpage>1733</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.2147/CLEP.S176923</pub-id><pub-id pub-id-type="pmid">30538577</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thygesen</surname><given-names>LC</given-names></name><name><surname>Daasnes</surname><given-names>C</given-names></name><name><surname>Thaulow</surname><given-names>I</given-names></name><name><surname>Brønnum-Hansen</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving</article-title><source>Scandinavian Journal of Public Health</source><volume>39</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1177/1403494811399956</pub-id><pub-id pub-id-type="pmid">21898916</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vives</surname><given-names>N</given-names></name><name><surname>Binefa</surname><given-names>G</given-names></name><name><surname>Vidal</surname><given-names>C</given-names></name><name><surname>Milà</surname><given-names>N</given-names></name><name><surname>Muñoz</surname><given-names>R</given-names></name><name><surname>Guardiola</surname><given-names>V</given-names></name><name><surname>Rial</surname><given-names>O</given-names></name><name><surname>Garcia</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in catalonia (spain)</article-title><source>Preventive Medicine</source><volume>155</volume><elocation-id>106929</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106929</pub-id><pub-id pub-id-type="pmid">34954239</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>MJ</given-names></name><name><surname>Meggetto</surname><given-names>O</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Espino-Hernández</surname><given-names>G</given-names></name><name><surname>Jembere</surname><given-names>N</given-names></name><name><surname>Bravo</surname><given-names>CA</given-names></name><name><surname>Rey</surname><given-names>M</given-names></name><name><surname>Aslam</surname><given-names>U</given-names></name><name><surname>Sheppard</surname><given-names>AJ</given-names></name><name><surname>Lofters</surname><given-names>AK</given-names></name><name><surname>Tammemägi</surname><given-names>MC</given-names></name><name><surname>Tinmouth</surname><given-names>J</given-names></name><name><surname>Kupets</surname><given-names>R</given-names></name><name><surname>Chiarelli</surname><given-names>AM</given-names></name><name><surname>Rabeneck</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in ontario, canada: a provincial, population-based study</article-title><source>Preventive Medicine</source><volume>151</volume><elocation-id>106586</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106586</pub-id><pub-id pub-id-type="pmid">34217413</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Quinn-Scoggins</surname><given-names>H</given-names></name><name><surname>Moriarty</surname><given-names>Y</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Goddard</surname><given-names>M</given-names></name><name><surname>Cannings-John</surname><given-names>R</given-names></name><name><surname>Whitelock</surname><given-names>V</given-names></name><name><surname>Whitaker</surname><given-names>KL</given-names></name><name><surname>Grozeva</surname><given-names>D</given-names></name><name><surname>Townson</surname><given-names>J</given-names></name><name><surname>Osborne</surname><given-names>K</given-names></name><name><surname>Smits</surname><given-names>S</given-names></name><name><surname>Robling</surname><given-names>M</given-names></name><name><surname>Hepburn</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>G</given-names></name><name><surname>Gjini</surname><given-names>A</given-names></name><name><surname>Brain</surname><given-names>K</given-names></name><name><surname>Waller</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: a mixed-methods study</article-title><source>Preventive Medicine</source><volume>153</volume><elocation-id>106826</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106826</pub-id><pub-id pub-id-type="pmid">34599921</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81808.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Franco</surname><given-names>Eduardo</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.08.18.22278786" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.18.22278786"/></front-stub><body><p>The authors convincingly demonstrate that, in the absence of any shutdowns, the Danish colorectal cancer screening program experienced only minor decreases in program participation during the COVID-19 pandemic period. This likely ensured ongoing program effectiveness in detecting early colorectal cancers and precancerous polyps. The evidence is solid and may serve as guidance for other countries when facing similar public health threats in the future.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81808.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Franco</surname><given-names>Eduardo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Giorgi Rossi</surname><given-names>Paolo</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/001bbwj30</institution-id><institution>Azienda Sanitaria Unità Locale di Reggio Emilia</institution></institution-wrap><country>Italy</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.08.18.22278786">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2022.08.18.22278786v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Nation-wide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by myself in a dual role of Reviewing Editor and Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Paolo Giorgi Rossi (Reviewer #2).</p><p>Essential revisions:</p><p>As is customary in <italic>eLife</italic>, the reviewers have discussed their critiques with one another and with the Reviewing and Senior Editors. The decision was reached by consensus. What follows below is an edited compilation of the essential and ancillary points provided by reviewers in their critiques and in their interaction post-review. Please submit a revised version that addresses these concerns directly. Although we expect that you will address these comments in your response letter, we also need to see the corresponding revision clearly marked in the text of the manuscript. Some of the reviewers' comments may seem to be simple queries or challenges that do not prompt revisions to the text. Please keep in mind, however, that readers may have the same perspective as the reviewers. Therefore, it is essential that you amend or expand the text to clarify the narrative accordingly.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>It would be useful to include a reference for the assertion that &quot;most&quot; programmes were paused – these references were included in the discussion but not in the introduction.</p><p>The language around &quot;short&quot;, &quot;medium&quot;, and &quot;long&quot; education are confusing from an English-language perspective, and do not appear to be standard.</p><p>The references to other countries, and the impact on screening and followup there, are a useful addition to the discussion – however, the inclusion of specific quantitative data would strengthen the comparisons. In particular, it is unclear whether countries such as Spain and England have since ensured that those that missed screening returned after the formal pauses. My understanding is that they have not, which would strengthen the argument that the approach in Denmark was superior.</p><p>I feel that a greater emphasis on the potential downstream impact on colorectal cancer diagnoses and deaths would make the point of the paper clearer – for instance, de Jonge et al. &quot;Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study&quot; and Mandrik et al. &quot;Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption&quot;. Screening is of course a means to an end, rather than an end itself, so this would contextualise the results for the reader.</p><p>Due to the nature of the study, the novelty is relatively limited – this is a very straightforward statistical analysis of screening registry data, and the subgroup analysis reveals few surprises. Ideally, such analysis would be provided by the registry themselves. In the absence of this though, I believe that it is important that this work is available to the public and I recommend publication.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The paper does not need any important changes. If the editors think this paper is not interesting enough, I suggest making one paper about the three screening programs in Denmark, instead of several companion papers. This would allow a comparative discussion and would make the papers less descriptive.</p><p>I have very few comments, since the paper is very well written and the report is rigorous, the methods well documented, tables and figure clear.</p><p>Abstract</p><p>No comment</p><p>Introduction</p><p>Line101-103: it is not clear the link between the sentence and the topic of the paper. It should be explained why you are talking about health seeking behaviors.</p><p>Methods</p><p>In the exposure of interest and in the outcome, it could be explained that the periods classify the date of invitation that is not the date of the event. It is not clear if the compliance to colonoscopy is classified on the day of invitation for colonoscopy of for FIT.</p><p>Discussion</p><p>The discussion is too long. Many paragraphs are very speculative. I appreciate the effort to give an interpretation of the observed phenomena in the light of other studies, but in some cases there is no other evidence or insight supporting the interpretation that sounds more common sense than interpretation (lines 359-369–lines 401 411).</p><p>Lines 430-432: the authors did not provide any evidence that participation to screening was safe, I mean attending clinics for colonoscopies. They did not provide data about the risk of SARS-CoV-2 infection of people attending endoscopic services.</p><p>Comparisons with data from other screening programs are the most interesting comments in the discussion, maybe only one paper focusing on differences would be more intriguing.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81808.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>It would be useful to include a reference for the assertion that &quot;most&quot; programmes were paused – these references were included in the discussion but not in the introduction.</p></disp-quote><p>Thank you for this comment. Additional references have been added in the Introduction and Discussion section (page 3, line 80 and page 9, line 340).</p><disp-quote content-type="editor-comment"><p>The language around &quot;short&quot;, &quot;medium&quot;, and &quot;long&quot; education are confusing from an English-language perspective, and do not appear to be standard.</p></disp-quote><p>Thank you for this comment. We have used the International Standard Classification of Education (ISCED) of the United Nations Education, Scientific and Cultural Organization (UNESCO) for the categorisation of educational level. ISCED 1-2 comprise primary education to upper secondary education, ISCED 3-5 comprise vocational education and training to vocational bachelors educations and ISCED 6-8 comprise bachelors programmes to PhD programmes. We have added this explanation in the Methods section (page 5, lines 200-205).</p><disp-quote content-type="editor-comment"><p>The references to other countries, and the impact on screening and followup there, are a useful addition to the discussion – however, the inclusion of specific quantitative data would strengthen the comparisons. In particular, it is unclear whether countries such as Spain and England have since ensured that those that missed screening returned after the formal pauses. My understanding is that they have not, which would strengthen the argument that the approach in Denmark was superior.</p></disp-quote><p>Thank you for this comment. We have elaborated on this in the Discussion section (page 9, lines 345-360 and pages 9-10, lines 367-379).</p><disp-quote content-type="editor-comment"><p>I feel that a greater emphasis on the potential downstream impact on colorectal cancer diagnoses and deaths would make the point of the paper clearer – for instance, de Jonge et al. &quot;Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study&quot; and Mandrik et al. &quot;Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption&quot;. Screening is of course a means to an end, rather than an end itself, so this would contextualise the results for the reader.</p></disp-quote><p>Thank you for this comment. We have elaborated on the potential downstream effect of colorectal cancer screening and added the mentioned references in the Discussion section (page 10, lines 381-405).</p><disp-quote content-type="editor-comment"><p>Due to the nature of the study, the novelty is relatively limited – this is a very straightforward statistical analysis of screening registry data, and the subgroup analysis reveals few surprises. Ideally, such analysis would be provided by the registry themselves. In the absence of this though, I believe that it is important that this work is available to the public and I recommend publication.</p></disp-quote><p>Thank you for this comment. These analyses are not provided routinely by the clinical quality registries.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The paper does not need any important changes. If the editors think this paper is not interesting enough, I suggest making one paper about the three screening programs in Denmark, instead of several companion papers. This would allow a comparative discussion and would make the papers less descriptive.</p><p>I have very few comments, since the paper is very well written and the report is rigorous, the methods well documented, tables and figure clear.</p><p>Introduction</p><p>Line101-103: it is not clear the link between the sentence and the topic of the paper. It should be explained why you are talking about health seeking behaviors.</p></disp-quote><p>Thank you for this comment. We have omitted this sentence.</p><disp-quote content-type="editor-comment"><p>Methods</p><p>In the exposure of interest and in the outcome, it could be explained that the periods classify the date of invitation that is not the date of the event. It is not clear if the compliance to colonoscopy is classified on the day of invitation for colonoscopy of for FIT.</p></disp-quote><p>Thank you for this comment. We have clarified this in the Methods section (page 5, lines 181-182 and 188-190).</p><disp-quote content-type="editor-comment"><p>Discussion</p><p>The discussion is too long. Many paragraphs are very speculative. I appreciate the effort to give an interpretation of the observed phenomena in the light of other studies, but in some cases there is no other evidence or insight supporting the interpretation that sounds more common sense than interpretation (lines 359-369–lines 401 411).</p></disp-quote><p>Thank you for this comment. We have shortened the Discussion section (pages 10-11, lines 407-439, page 11, lines 449-454 and 461-471 and page 12, lines 496-197).</p><disp-quote content-type="editor-comment"><p>Lines 430-432: the authors did not provide any evidence that participation to screening was safe, I mean attending clinics for colonoscopies. They did not provide data about the risk of SARS-CoV-2 infection of people attending endoscopic services.</p></disp-quote><p>Thank you for this comment. We have re-phrased this sentence (page 12, line 492).</p><disp-quote content-type="editor-comment"><p>Comparisons with data from other screening programs are the most interesting comments in the discussion, maybe only one paper focusing on differences would be more intriguing.</p></disp-quote><p>Additional changes:</p><p>We have omitted Supplementary Figure 2 and 3 (stratification by explanatory variables) as these data are already displayed in Supplementary Table 1 and 4.</p></body></sub-article></article>